{"PubmedArticle":[{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"29174593","DateCompleted":{"Year":"2019","Month":"06","Day":"18"},"DateRevised":{"Year":"2020","Month":"03","Day":"11"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1873-2402","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"83","Issue":"5","PubDate":{"Year":"2018","Month":"03","Day":"01"}},"Title":"Biological psychiatry","ISOAbbreviation":"Biol Psychiatry"},"ArticleTitle":"Brain Regions Showing White Matter Loss in\u00a0Huntington's Disease Are Enriched for Synaptic and Metabolic Genes.","Pagination":{"MedlinePgn":"456-465"},"ELocationID":["S0006-3223(17)32129-7","10.1016\/j.biopsych.2017.10.019"],"Abstract":{"AbstractText":["The earliest white matter changes in Huntington's disease are seen before disease onset in the premanifest stage around the striatum, within the corpus callosum, and in posterior white matter tracts. While experimental evidence suggests that these changes may be related to abnormal gene transcription, we lack an understanding of the biological processes driving this regional vulnerability.","Here, we investigate the relationship between regional transcription in the healthy brain, using the Allen Institute for Brain Science transcriptome atlas, and regional white matter connectivity loss at three time points over 24 months in subjects with premanifest Huntington's disease relative to control participants. The baseline cohort included 72 premanifest Huntington's disease participants and 85 healthy control participants.","We show that loss of corticostriatal, interhemispheric, and intrahemispheric white matter connections at baseline and over 24 months in premanifest Huntington's disease is associated with gene expression profiles enriched for synaptic genes and metabolic genes. Corticostriatal gene expression profiles are predominately associated with motor, parietal, and occipital regions, while interhemispheric expression profiles are associated with frontotemporal regions. We also show that genes with known abnormal transcription in human Huntington's disease and animal models are overrepresented in synaptic gene expression profiles, but not in metabolic gene expression profiles.","These findings suggest a dual mechanism of white matter vulnerability in Huntington's disease, in which abnormal transcription of synaptic genes and metabolic disturbance not related to transcription may drive white matter loss."],"CopyrightInformation":"Copyright \u00a9 2017 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"McColgan","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"Huntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gregory","ForeName":"Sarah","Initials":"S","AffiliationInfo":{"Affiliation":"Huntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Seunarine","ForeName":"Kiran K","Initials":"KK","AffiliationInfo":{"Affiliation":"Developmental Imaging and Biophysics Section, UCL Institute of Child Health, Queen Square, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Razi","ForeName":"Adeel","Initials":"A","AffiliationInfo":{"Affiliation":"Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, Queen Square, London, United Kingdom; Department of Electronic Engineering, NED University of Engineering and Technology, Karachi, Pakistan."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Papoutsi","ForeName":"Marina","Initials":"M","AffiliationInfo":{"Affiliation":"Huntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Johnson","ForeName":"Eileanoir","Initials":"E","AffiliationInfo":{"Affiliation":"Huntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Durr","ForeName":"Alexandra","Initials":"A","AffiliationInfo":{"Affiliation":"APHP Department of Genetics, University Hospital Piti\u00e9-Salp\u00eatri\u00e8re; and ICM (Brain and Spine Institute) INSERM U1127, CNRS UMR7225, Sorbonne Universit\u00e9s - UPMC Paris VI UMR_S1127, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Roos","ForeName":"Raymund A C","Initials":"RAC","AffiliationInfo":{"Affiliation":"Department of Neurology, Leiden University Medical Centre, Leiden, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Leavitt","ForeName":"Blair R","Initials":"BR","AffiliationInfo":{"Affiliation":"Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, Vancouver, British Columbia, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Holmans","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"MRC Centre for Neuropsychiatric Genetics and Genomics, School of Medicine, Cardiff University, Cardiff, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Scahill","ForeName":"Rachael I","Initials":"RI","AffiliationInfo":{"Affiliation":"Huntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris A","Initials":"CA","AffiliationInfo":{"Affiliation":"Developmental Imaging and Biophysics Section, UCL Institute of Child Health, Queen Square, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rees","ForeName":"Geraint","Initials":"G","AffiliationInfo":{"Affiliation":"Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, Queen Square, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tabrizi","ForeName":"Sarah J","Initials":"SJ","AffiliationInfo":{"Affiliation":"Huntington's Disease Centre, Department of Neurodegenerative Disease, Queen Square, London, United Kingdom; National Hospital for Neurology and Neurosurgery, Queen Square, London, United Kingdom. Electronic address: s.tabrizi@ucl.ac.uk."}},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Track-On HD Investigators"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"103437\/Z\/13\/Z ","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"091593\/Z\/10\/Z","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"200181\/Z\/15\/Z","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"MR\/L012936\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"MR\/L010305\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/P007015\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/K023268\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/L02053X\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2017","Month":"10","Day":"26"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Biol Psychiatry","NlmUniqueID":"0213264","ISSNLinking":"0006-3223"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Cerebral Cortex","QualifierName":["diagnostic imaging","metabolism","pathology"]},{"DescriptorName":"Corpus Striatum","QualifierName":["diagnostic imaging","metabolism","pathology"]},{"DescriptorName":"Cross-Sectional Studies"},{"DescriptorName":"Diffusion Tensor Imaging"},{"DescriptorName":"Follow-Up Studies"},{"DescriptorName":"Gene Expression","QualifierName":"genetics"},{"DescriptorName":"Gene Expression Profiling"},{"DescriptorName":"Humans"},{"DescriptorName":"Huntington Disease","QualifierName":["diagnostic imaging","genetics","metabolism","pathology"]},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Nerve Net","QualifierName":["diagnostic imaging","metabolism","pathology"]},{"DescriptorName":"Prodromal Symptoms"},{"DescriptorName":"Transcriptome","QualifierName":"genetics"},{"DescriptorName":"White Matter","QualifierName":["diagnostic imaging","metabolism","pathology"]}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Connectome","Genetics","Huntington's disease","Imaging","Transcription","White matter"]},"InvestigatorList":{"Investigator":[{"@attributes":{"ValidYN":"Y"},"LastName":"Coleman","ForeName":"A","Initials":"A","AffiliationInfo":{"Affiliation":"University of British Columbia, Vancouver, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Decolongon","ForeName":"J","Initials":"J","AffiliationInfo":{"Affiliation":"University of British Columbia, Vancouver, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Fan","ForeName":"M","Initials":"M","AffiliationInfo":{"Affiliation":"University of British Columbia, Vancouver, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Petkau","ForeName":"T","Initials":"T","AffiliationInfo":{"Affiliation":"University of British Columbia, Vancouver, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Jauffret","ForeName":"C","Initials":"C","AffiliationInfo":{"Affiliation":"ICM and APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Justo","ForeName":"D","Initials":"D","AffiliationInfo":{"Affiliation":"ICM and APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Lehericy","ForeName":"S","Initials":"S","AffiliationInfo":{"Affiliation":"ICM and APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Nigaud","ForeName":"K","Initials":"K","AffiliationInfo":{"Affiliation":"ICM and APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Valabr\u00e8gue","ForeName":"R","Initials":"R","AffiliationInfo":{"Affiliation":"ICM and APHP, Piti\u00e9-Salp\u00eatri\u00e8re University Hospital, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Schoonderbeek","ForeName":"A","Initials":"A","AffiliationInfo":{"Affiliation":"Leiden University Medical Centre, Leiden, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"'t Hart","ForeName":"E P","Initials":"EP","AffiliationInfo":{"Affiliation":"Leiden University Medical Centre, Leiden, the Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Moss","ForeName":"D J Hensman","Initials":"DJH","AffiliationInfo":{"Affiliation":"University College London, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Ghosh","ForeName":"R","Initials":"R","AffiliationInfo":{"Affiliation":"University College London, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Crawford","ForeName":"H","Initials":"H","AffiliationInfo":{"Affiliation":"University College London, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Papoutsi","ForeName":"M","Initials":"M","AffiliationInfo":{"Affiliation":"University College London, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Berna","ForeName":"C","Initials":"C","AffiliationInfo":{"Affiliation":"University College London, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mahaleskshmi","ForeName":"D","Initials":"D","AffiliationInfo":{"Affiliation":"University College London, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Reilmann","ForeName":"R","Initials":"R","AffiliationInfo":{"Affiliation":"George Huntington Institute, M\u00fcnster, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Weber","ForeName":"N","Initials":"N","AffiliationInfo":{"Affiliation":"George Huntington Institute, M\u00fcnster, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Labuschagne","ForeName":"I","Initials":"I","AffiliationInfo":{"Affiliation":"Monash University, Melbourne, Australia."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stout","ForeName":"J","Initials":"J","AffiliationInfo":{"Affiliation":"Monash University, Melbourne, Australia."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Landwehrmeyer","ForeName":"B","Initials":"B","AffiliationInfo":{"Affiliation":"University of Ulm, Ulm, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Orth","ForeName":"M","Initials":"M","AffiliationInfo":{"Affiliation":"University of Ulm, Ulm, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Mayer","ForeName":"I","Initials":"I","AffiliationInfo":{"Affiliation":"University of Ulm, Ulm, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Johnson","ForeName":"H","Initials":"H","AffiliationInfo":{"Affiliation":"University of Iowa, Iowa City, IA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Crawfurd","ForeName":"D","Initials":"D","AffiliationInfo":{"Affiliation":"University of Manchester, Manchester, United Kingdom."}}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2017","Month":"04","Day":"19"},{"@attributes":{"PubStatus":"revised"},"Year":"2017","Month":"10","Day":"05"},{"@attributes":{"PubStatus":"accepted"},"Year":"2017","Month":"10","Day":"07"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"11","Day":"28","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2019","Month":"6","Day":"19","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"11","Day":"28","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["29174593","S0006-3223(17)32129-7","10.1016\/j.biopsych.2017.10.019","PMC5803509"]},"ReferenceList":{"Reference":[{"Citation":"Nat Neurosci. 2014 Oct;17 (10 ):1418-1428","ArticleIdList":{"ArticleId":"25174004"}},{"Citation":"Nature. 2011 Oct 26;478(7370):483-9","ArticleIdList":{"ArticleId":"22031440"}},{"Citation":"Proc Natl Acad Sci U S A. 2008 Mar 4;105(9):3467-72","ArticleIdList":{"ArticleId":"18299573"}},{"Citation":"Science. 2015 Jun 12;348(6240):1241-4","ArticleIdList":{"ArticleId":"26068849"}},{"Citation":"Lancet Neurol. 2011 Jan;10 (1):83-98","ArticleIdList":{"ArticleId":"21163446"}},{"Citation":"Cell. 2015 Jul 30;162(3):516-26","ArticleIdList":{"ArticleId":"26232222"}},{"Citation":"Ann Neurol. 2000 Jan;47(1):80-6","ArticleIdList":{"ArticleId":"10632104"}},{"Citation":"Neuroimage. 2015 Jan 1;104:253-65","ArticleIdList":{"ArticleId":"25312774"}},{"Citation":"Cereb Cortex. 2012 Dec;22(12):2858-66","ArticleIdList":{"ArticleId":"22223853"}},{"Citation":"Med Phys. 2011 Sep;38(9):5239-53","ArticleIdList":{"ArticleId":"21978068"}},{"Citation":"Lancet Neurol. 2017 Sep;16(9):701-711","ArticleIdList":{"ArticleId":"28642124"}},{"Citation":"BMC Bioinformatics. 2009 Feb 03;10:48","ArticleIdList":{"ArticleId":"19192299"}},{"Citation":"Lancet Neurol. 2011 Jan;10 (1):31-42","ArticleIdList":{"ArticleId":"21130037"}},{"Citation":"Lancet Neurol. 2009 Sep;8(9):791-801","ArticleIdList":{"ArticleId":"19646924"}},{"Citation":"Eur J Neurosci. 2003 Sep;18(5):1093-102","ArticleIdList":{"ArticleId":"12956709"}},{"Citation":"Neuroimage. 2015 Oct 1;119:338-51","ArticleIdList":{"ArticleId":"26163802"}},{"Citation":"Nature. 2012 Sep 20;489(7416):391-399","ArticleIdList":{"ArticleId":"22996553"}},{"Citation":"Nat Rev Dis Primers. 2015 Apr 23;1:15005","ArticleIdList":{"ArticleId":"27188817"}},{"Citation":"Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):9105-10","ArticleIdList":{"ArticleId":"27457931"}},{"Citation":"Proc Natl Acad Sci U S A. 2016 Jan 26;113(4):E469-78","ArticleIdList":{"ArticleId":"26739559"}},{"Citation":"Elife. 2015 Sep 07;4:null","ArticleIdList":{"ArticleId":"26344547"}},{"Citation":"PLoS Genet. 2007 Aug;3(8):e135","ArticleIdList":{"ArticleId":"17708681"}},{"Citation":"J Neurosci. 2011 Jun 29;31(26):9544-53","ArticleIdList":{"ArticleId":"21715619"}},{"Citation":"Neuron. 2012 Mar 22;73(6):1216-27","ArticleIdList":{"ArticleId":"22445348"}},{"Citation":"J Neural Transm (Vienna). 2015 Jul;122(7):1055-68","ArticleIdList":{"ArticleId":"25119539"}},{"Citation":"Nat Neurosci. 2016 Apr;19(4):623-33","ArticleIdList":{"ArticleId":"26900923"}},{"Citation":"JCI Insight. 2017 Apr 20;2(8):null","ArticleIdList":{"ArticleId":"28422761"}},{"Citation":"Philos Trans R Soc Lond B Biol Sci. 2016 Oct 5;371(1705):","ArticleIdList":{"ArticleId":"27574314"}},{"Citation":"Hum Mol Genet. 2016 Jul 15;25(14 ):2893-2904","ArticleIdList":{"ArticleId":"27170315"}},{"Citation":"Neurobiol Aging. 2016 Dec;48:153-160","ArticleIdList":{"ArticleId":"27697694"}},{"Citation":"NMR Biomed. 2013 Dec;26(12):1775-86","ArticleIdList":{"ArticleId":"24038308"}},{"Citation":"Neuroimage. 2006 Jul 1;31(3):968-80","ArticleIdList":{"ArticleId":"16530430"}},{"Citation":"Neuron. 2016 Mar 2;89(5):910-26","ArticleIdList":{"ArticleId":"26938440"}},{"Citation":"J Pharmacol Exp Ther. 2010 Oct;335(1):13-22","ArticleIdList":{"ArticleId":"20624994"}},{"Citation":"Hum Mol Genet. 2016 Jul 1;25(13):2621-2632","ArticleIdList":{"ArticleId":"27126634"}},{"Citation":"J Neuropathol Exp Neurol. 2010 Sep;69(9):880-95","ArticleIdList":{"ArticleId":"20720508"}},{"Citation":"Neuroimage Clin. 2016 Feb 26;11:450-60","ArticleIdList":{"ArticleId":"27104139"}},{"Citation":"Proc Natl Acad Sci U S A. 2013 Feb 5;110(6):2366-70","ArticleIdList":{"ArticleId":"23341618"}},{"Citation":"Hum Mol Genet. 2006 Mar 15;15(6):965-77","ArticleIdList":{"ArticleId":"16467349"}},{"Citation":"Hum Brain Mapp. 2013 Nov;34(11):2747-66","ArticleIdList":{"ArticleId":"22611035"}},{"Citation":"Curr Opin Neurobiol. 2015 Aug;33:53-62","ArticleIdList":{"ArticleId":"25700146"}},{"Citation":"Neurosci Bull. 2012 Oct;28(5):517-31","ArticleIdList":{"ArticleId":"22961474"}},{"Citation":"Curr Opin Pharmacol. 2016 Feb;26:33-8","ArticleIdList":{"ArticleId":"26461267"}},{"Citation":"Neurobiol Dis. 2012 Jan;45(1):83-98","ArticleIdList":{"ArticleId":"21820514"}},{"Citation":"Nat Neurosci. 2015 Dec;18(12):1832-44","ArticleIdList":{"ArticleId":"26571460"}},{"Citation":"Neuron. 2009 Apr 16;62(1):42-52","ArticleIdList":{"ArticleId":"19376066"}},{"Citation":"EBioMedicine. 2015 Aug 04;2(10 ):1420-9","ArticleIdList":{"ArticleId":"26629536"}},{"Citation":"Brain. 2016 Oct;139(Pt 10):2778-2791","ArticleIdList":{"ArticleId":"27497488"}},{"Citation":"Neuroimage. 2015 Apr 1;109:341-56","ArticleIdList":{"ArticleId":"25555998"}},{"Citation":"Biol Psychiatry. 2017 Mar 15;81(6):495-502","ArticleIdList":{"ArticleId":"27720199"}},{"Citation":"Hum Brain Mapp. 2012 Jan;33(1):203-12","ArticleIdList":{"ArticleId":"21264990"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"28294457","DateCompleted":{"Year":"2018","Month":"03","Day":"01"},"DateRevised":{"Year":"2020","Month":"03","Day":"11"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1097-0193","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"38","Issue":"6","PubDate":{"Year":"2017","Month":"06"}},"Title":"Human brain mapping","ISOAbbreviation":"Hum Brain Mapp"},"ArticleTitle":"Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease.","Pagination":{"MedlinePgn":"2819-2829"},"ELocationID":"10.1002\/hbm.23527","Abstract":{"AbstractText":"Depression is common in premanifest Huntington's disease (preHD) and results in significant morbidity. We sought to examine how variations in structural and functional brain networks relate to depressive symptoms in premanifest HD and healthy controls. Brain networks were constructed using diffusion tractography (70 preHD and 81 controls) and resting state fMRI (92 preHD and 94 controls) data. A sub-network associated with depression was identified in a data-driven fashion and network-based statistics was used to investigate which specific connections correlated with depression scores. A replication analysis was then performed using data from a separate study. Correlations between depressive symptoms with increased functional connectivity and decreased structural connectivity were seen for connections in the default mode network (DMN) and basal ganglia in preHD. This study reveals specific connections in the DMN and basal ganglia that are associated with depressive symptoms in preHD. Hum Brain Mapp 38:2819-2829, 2017. \u00a9 2017 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc.","CopyrightInformation":"\u00a9 2017 The Authors Human Brain Mapping Published by Wiley Periodicals, Inc."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"McColgan","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Razi","ForeName":"Adeel","Initials":"A","AffiliationInfo":[{"Affiliation":"Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, WC1N 3BG, United Kingdom."},{"Affiliation":"Department of Electronic Engineering, NED University of Engineering and Technology, Karachi, Pakistan."}]},{"@attributes":{"ValidYN":"Y"},"LastName":"Gregory","ForeName":"Sarah","Initials":"S","AffiliationInfo":{"Affiliation":"Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, WC1N 3BG, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Seunarine","ForeName":"Kiran K","Initials":"KK","AffiliationInfo":{"Affiliation":"Developmental Imaging and Biophysics Section, UCL Institute of Child Health, London, WC1N 1EH, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Durr","ForeName":"Alexandra","Initials":"A","AffiliationInfo":{"Affiliation":"APHP Department of Genetics, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, and Institut du Cerveau et de la Moelle, INSERM U1127, CNRS UMR7225, Sorbonne Universit\u00e9s - UPMC Universit\u00e9 Paris VI UMR_S1127, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"A C Roos","ForeName":"Raymund","Initials":"R","AffiliationInfo":{"Affiliation":"Department of Neurology, Leiden University Medical Centre, 2300RC Leiden, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Leavitt","ForeName":"Blair R","Initials":"BR","AffiliationInfo":{"Affiliation":"Centre for Molecular Medicine and Therapeutics, Department of Medical Genetics, University of British Columbia, 950 West 28th Avenue, Vancouver, British Columbia, V5Z 4H4, Canada."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Scahill","ForeName":"Rachael I","Initials":"RI","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris A","Initials":"CA","AffiliationInfo":{"Affiliation":"Developmental Imaging and Biophysics Section, UCL Institute of Child Health, London, WC1N 1EH, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Langbehn","ForeName":"Doug R","Initials":"DR","AffiliationInfo":{"Affiliation":"Department of Biostatistics, University of Iowa, Iowa City, Iowa."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rees","ForeName":"Geraint","Initials":"G","AffiliationInfo":{"Affiliation":"Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, WC1N 3BG, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tabrizi","ForeName":"Sarah J","Initials":"SJ","AffiliationInfo":[{"Affiliation":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, United Kingdom."},{"Affiliation":"National Hospital for Neurology and Neurosurgery, Queen Square, London, WC1N 3BG, United Kingdom."}]},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Track On-HD Investigators"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"200181\/Z\/15\/Z","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"MR\/L012936\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/L02053X\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/P007015\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2017","Month":"03","Day":"15"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Hum Brain Mapp","NlmUniqueID":"9419065","ISSNLinking":"1065-9471"},"ChemicalList":{"Chemical":{"RegistryNumber":"S88TT14065","NameOfSubstance":"Oxygen"}},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Apathy"},{"DescriptorName":"Brain","QualifierName":["diagnostic imaging","physiopathology"]},{"DescriptorName":"Brain Mapping"},{"DescriptorName":"Cohort Studies"},{"DescriptorName":"Depressive Disorder","QualifierName":["etiology","pathology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Huntington Disease","QualifierName":"complications"},{"DescriptorName":"Image Processing, Computer-Assisted"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Neural Pathways","QualifierName":["diagnostic imaging","pathology","physiopathology"]},{"DescriptorName":"Oxygen","QualifierName":"blood"},{"DescriptorName":"Psychiatric Status Rating Scales"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Huntington's disease","brain network","depression","diffusion tractography","functional MRI"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2016","Month":"09","Day":"06"},{"@attributes":{"PubStatus":"revised"},"Year":"2016","Month":"11","Day":"25"},{"@attributes":{"PubStatus":"accepted"},"Year":"2016","Month":"12","Day":"15"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2017","Month":"3","Day":"16","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2018","Month":"3","Day":"2","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2017","Month":"3","Day":"16","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["28294457","10.1002\/hbm.23527","PMC5434856"]},"ReferenceList":{"Reference":[{"Citation":"Psychol Med. 2014 Jul;44(9):1867-78","ArticleIdList":{"ArticleId":"24093462"}},{"Citation":"Proc Natl Acad Sci U S A. 2012 Apr 3;109(14):5464-8","ArticleIdList":{"ArticleId":"22431642"}},{"Citation":"Neuroimage. 2013 Feb 15;67:298-312","ArticleIdList":{"ArticleId":"23238430"}},{"Citation":"Parkinsonism Relat Disord. 2016 Apr;25:58-64","ArticleIdList":{"ArticleId":"26898966"}},{"Citation":"Neuroimage. 2007 Aug 1;37(1):90-101","ArticleIdList":{"ArticleId":"17560126"}},{"Citation":"J Neuropsychiatry Clin Neurosci. 2012 Winter;24(1):53-60","ArticleIdList":{"ArticleId":"22450614"}},{"Citation":"J Psychiatr Res. 2013 Oct;47(10 ):1423-31","ArticleIdList":{"ArticleId":"23790259"}},{"Citation":"Biol Psychiatry. 2007 Sep 1;62(5):429-37","ArticleIdList":{"ArticleId":"17210143"}},{"Citation":"J Neuropsychiatry Clin Neurosci. 1998 Summer;10(3):314-9","ArticleIdList":{"ArticleId":"9706539"}},{"Citation":"Lancet Neurol. 2009 Sep;8(9):791-801","ArticleIdList":{"ArticleId":"19646924"}},{"Citation":"Nature. 2015 Apr 9;520(7546):224-9","ArticleIdList":{"ArticleId":"25607358"}},{"Citation":"J Neurosci. 2011 Nov 2;31(44):15775-86","ArticleIdList":{"ArticleId":"22049421"}},{"Citation":"Nat Rev Neurol. 2014 Apr;10 (4):204-16","ArticleIdList":{"ArticleId":"24614516"}},{"Citation":"Comput Methods Programs Biomed. 2010 Jun;98(3):278-84","ArticleIdList":{"ArticleId":"19818524"}},{"Citation":"Neuroimage. 2010 Sep;52(3):1059-69","ArticleIdList":{"ArticleId":"19819337"}},{"Citation":"Neuroimage. 2010 Dec;53(4):1197-207","ArticleIdList":{"ArticleId":"20600983"}},{"Citation":"Neuroimage. 2006 Jul 1;31(3):968-80","ArticleIdList":{"ArticleId":"16530430"}},{"Citation":"Mov Disord. 2011 Aug 1;26(9):1684-90","ArticleIdList":{"ArticleId":"21557312"}},{"Citation":"Psychiatry Res. 2010 Jul 30;178(2):414-8","ArticleIdList":{"ArticleId":"20471695"}},{"Citation":"J Neurol. 2013 Oct;260(10):2481-90","ArticleIdList":{"ArticleId":"23793818"}},{"Citation":"Psychiatry Res. 2002 Jun 15;114(2):103-11","ArticleIdList":{"ArticleId":"12036510"}},{"Citation":"J Neuropsychiatry Clin Neurosci. 2009 Summer;21(3):266-70","ArticleIdList":{"ArticleId":"19776305"}},{"Citation":"Brain. 2010 Apr;133(Pt 4):1111-27","ArticleIdList":{"ArticleId":"20237128"}},{"Citation":"Biol Psychiatry. 2013 Jul 1;74(1):48-54","ArticleIdList":{"ArticleId":"23273724"}},{"Citation":"Exp Neurol. 2013 Jan;239:218-28","ArticleIdList":{"ArticleId":"23123406"}},{"Citation":"Biol Psychiatry. 2015 Feb 1;77(3):223-35","ArticleIdList":{"ArticleId":"25444171"}},{"Citation":"EBioMedicine. 2015 Aug 04;2(10 ):1420-9","ArticleIdList":{"ArticleId":"26629536"}},{"Citation":"Psychiatry Res. 2012 Aug-Sep;203(2-3):166-74","ArticleIdList":{"ArticleId":"22974690"}},{"Citation":"Cereb Cortex. 2008 Aug;18(8):1856-64","ArticleIdList":{"ArticleId":"18063564"}},{"Citation":"Hum Brain Mapp. 2002 Nov;17(3):143-55","ArticleIdList":{"ArticleId":"12391568"}},{"Citation":"Ann N Y Acad Sci. 2008 Mar;1124:1-38","ArticleIdList":{"ArticleId":"18400922"}},{"Citation":"Brain Connect. 2012;2(3):125-41","ArticleIdList":{"ArticleId":"22642651"}},{"Citation":"Brain. 2015 Nov;138(Pt 11):3327-44","ArticleIdList":{"ArticleId":"26384928"}},{"Citation":"Proc Natl Acad Sci U S A. 2010 Jun 15;107(24):11020-5","ArticleIdList":{"ArticleId":"20534464"}},{"Citation":"Biol Psychiatry. 2014 Oct 1;76(7):567-74","ArticleIdList":{"ArticleId":"24690111"}},{"Citation":"J Neuropsychol. 2013 Sep;7(2):255-83","ArticleIdList":{"ArticleId":"23621377"}},{"Citation":"J Huntingtons Dis. 2015;4(1):49-59","ArticleIdList":{"ArticleId":"26333257"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):939-43","ArticleIdList":{"ArticleId":"17178819"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"26384928","DateCompleted":{"Year":"2016","Month":"02","Day":"09"},"DateRevised":{"Year":"2020","Month":"03","Day":"11"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1460-2156","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"138","Issue":"Pt 11","PubDate":{"Year":"2015","Month":"Nov"}},"Title":"Brain : a journal of neurology","ISOAbbreviation":"Brain"},"ArticleTitle":"Selective vulnerability of Rich Club brain regions is an organizational principle of structural connectivity loss in Huntington's disease.","Pagination":{"MedlinePgn":"3327-44"},"ELocationID":"10.1093\/brain\/awv259","Abstract":{"AbstractText":"Huntington's disease can be predicted many years before symptom onset, and thus makes an ideal model for studying the earliest mechanisms of neurodegeneration. Diffuse patterns of structural connectivity loss occur in the basal ganglia and cortex early in the disease. However, the organizational principles that underlie these changes are unclear. By understanding such principles we can gain insight into the link between the cellular pathology caused by mutant huntingtin and its downstream effect at the macroscopic level. The 'rich club' is a pattern of organization established in healthy human brains, where specific hub 'rich club' brain regions are more highly connected to each other than other brain regions. We hypothesized that selective loss of rich club connectivity might represent an organizing principle underlying the distributed pattern of structural connectivity loss seen in Huntington's disease. To test this hypothesis we performed diffusion tractography and graph theoretical analysis in a pseudo-longitudinal study of 50 premanifest and 38 manifest Huntington's disease participants compared with 47 healthy controls. Consistent with our hypothesis we found that structural connectivity loss selectively affected rich club brain regions in premanifest and manifest Huntington's disease participants compared with controls. We found progressive network changes across controls, premanifest Huntington's disease and manifest Huntington's disease characterized by increased network segregation in the premanifest stage and loss of network integration in manifest disease. These regional and whole brain network differences were highly correlated with cognitive and motor deficits suggesting they have pathophysiological relevance. We also observed greater reductions in the connectivity of brain regions that have higher network traffic and lower clustering of neighbouring regions. This provides a potential mechanism that results in a characteristic pattern of structural connectivity loss targeting highly connected brain regions with high network traffic and low clustering of neighbouring regions. Our findings highlight the role of the rich club as a substrate for the structural connectivity loss seen in Huntington's disease and have broader implications for understanding the connection between molecular and systems level pathology in neurodegenerative disease. ","CopyrightInformation":"\u00a9 The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"McColgan","ForeName":"Peter","Initials":"P","AffiliationInfo":{"Affiliation":"1 Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK s.tabrizi@ucl.ac.uk g.rees@ucl.ac.uk."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Seunarine","ForeName":"Kiran K","Initials":"KK","AffiliationInfo":{"Affiliation":"2 Developmental Imaging and Biophysics Section, UCL Institute of Child Health, London, WC1N 1EH, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Razi","ForeName":"Adeel","Initials":"A","AffiliationInfo":{"Affiliation":"3 Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, WC1N 3BG, UK 4 Department of Electronic Engineering, NED University of Engineering and Technology, Karachi, Pakistan."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Cole","ForeName":"James H","Initials":"JH","AffiliationInfo":{"Affiliation":"5 Computational, Cognitive and Clinical Neuroimaging Laboratory, Department of Medicine, Imperial College London, W12 0HS, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gregory","ForeName":"Sarah","Initials":"S","AffiliationInfo":{"Affiliation":"3 Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, WC1N 3BG, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Durr","ForeName":"Alexandra","Initials":"A","AffiliationInfo":{"Affiliation":"6 APHP Department of Genetics, Groupe Hospitalier Piti\u00e9-Salp\u00eatri\u00e8re, and Institut du Cerveau et de la Moelle, INSERM U1127, CNRS UMR7225, Sorbonne Universit\u00e9s - UPMC Universit\u00e9 Paris VI UMR_S1127, Paris, France."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Roos","ForeName":"Raymund A C","Initials":"RA","AffiliationInfo":{"Affiliation":"7 Department of Neurology, Leiden University Medical Centre, 2300RC Leiden, The Netherlands."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Stout","ForeName":"Julie C","Initials":"JC","AffiliationInfo":{"Affiliation":"8 School of Psychological Sciences, Monash University, VIC, Australia."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Landwehrmeyer","ForeName":"Bernhard","Initials":"B","AffiliationInfo":{"Affiliation":"9 Department of Neurology, University of Ulm, Oberer Eselsberg 45-1, D-89081, Ulm, Germany."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Scahill","ForeName":"Rachael I","Initials":"RI","AffiliationInfo":{"Affiliation":"1 Department of Neurodegenerative Disease, UCL Institute of Neurology, London, WC1N 3BG, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris A","Initials":"CA","AffiliationInfo":{"Affiliation":"2 Developmental Imaging and Biophysics Section, UCL Institute of Child Health, London, WC1N 1EH, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Rees","ForeName":"Geraint","Initials":"G","AffiliationInfo":{"Affiliation":"3 Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, WC1N 3BG, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tabrizi","ForeName":"Sarah J","Initials":"SJ"},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Track-HD Investigators"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"G1002276","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/L02053X\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"515103","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"091593\/Z\/10\/Z","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"100227","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"091593","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"G0300117","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/L012936\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2015","Month":"09","Day":"17"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Brain","NlmUniqueID":"0372537","ISSNLinking":"0006-8950"},"CitationSubset":["AIM","IM"],"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Basal Ganglia","QualifierName":"pathology"},{"DescriptorName":"Brain","QualifierName":"pathology"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Caudate Nucleus","QualifierName":"pathology"},{"DescriptorName":"Cerebral Cortex","QualifierName":"pathology"},{"DescriptorName":"Diffusion Magnetic Resonance Imaging"},{"DescriptorName":"Diffusion Tensor Imaging"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Huntington Disease","QualifierName":"pathology"},{"DescriptorName":"Image Processing, Computer-Assisted"},{"DescriptorName":"Longitudinal Studies"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neostriatum","QualifierName":"pathology"},{"DescriptorName":"Neural Pathways","QualifierName":"pathology"},{"DescriptorName":"Putamen","QualifierName":"pathology"},{"DescriptorName":"Thalamus","QualifierName":"pathology"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Huntington\u2019s disease","rich club","tractography"]},"InvestigatorList":{"Investigator":[{"@attributes":{"ValidYN":"Y"},"LastName":"Bohlen","ForeName":"Stefan","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Crawford","ForeName":"Helen","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hart","ForeName":"Ellen P","Initials":"EP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hobbs","ForeName":"Nicola Z","Initials":"NZ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Jauffret","ForeName":"Celine","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Francisque","ForeName":"H\u00e9l\u00e8ne","Initials":"H"},{"@attributes":{"ValidYN":"Y"},"LastName":"Labuschagne","ForeName":"Izelle","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lahiri","ForeName":"Nayana","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lehericy","ForeName":"St\u00e9phane","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Monin","ForeName":"Marie Laure","Initials":"ML"},{"@attributes":{"ValidYN":"Y"},"LastName":"Malone","ForeName":"Ian","Initials":"I"},{"@attributes":{"ValidYN":"Y"},"LastName":"O'Regan","ForeName":"Alison","Initials":"A"},{"@attributes":{"ValidYN":"Y"},"LastName":"Queller","ForeName":"Sarah","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Read","ForeName":"Joy","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Reilmann","ForeName":"Ralf","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"R\u00f6dig","ForeName":"Verena","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Valabr\u00e8gue","ForeName":"Romain","Initials":"R"},{"@attributes":{"ValidYN":"Y"},"LastName":"van der Grond","ForeName":"Jeroen","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Whitehead","ForeName":"Daisy","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Ttita","ForeName":"Felix","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vitkin","ForeName":"Katja","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kelm","ForeName":"Theresia","Initials":"T"},{"@attributes":{"ValidYN":"Y"},"LastName":"Scherer","ForeName":"Rosine","Initials":"R"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2015","Month":"02","Day":"06"},{"@attributes":{"PubStatus":"accepted"},"Year":"2015","Month":"07","Day":"22"},{"@attributes":{"PubStatus":"entrez"},"Year":"2015","Month":"9","Day":"20","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2015","Month":"9","Day":"20","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"2","Day":"10","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["26384928","awv259","10.1093\/brain\/awv259","PMC4620513"]},"ReferenceList":{"Reference":[{"Citation":"PLoS Comput Biol. 2010;6(11):e1001006","ArticleIdList":{"ArticleId":"21124954"}},{"Citation":"Neuroimage. 2013 Feb 15;67:298-312","ArticleIdList":{"ArticleId":"23238430"}},{"Citation":"Lancet Neurol. 2013 Jul;12(7):637-49","ArticleIdList":{"ArticleId":"23664844"}},{"Citation":"Curr Alzheimer Res. 2014;11(8):755-64","ArticleIdList":{"ArticleId":"25212914"}},{"Citation":"Neuroimage. 2015 Jan 1;104:253-65","ArticleIdList":{"ArticleId":"25312774"}},{"Citation":"Med Phys. 2011 Sep;38(9):5239-53","ArticleIdList":{"ArticleId":"21978068"}},{"Citation":"Clin Genet. 2004 Apr;65(4):267-77","ArticleIdList":{"ArticleId":"15025718"}},{"Citation":"Neuropsychologia. 2011 Jan;49(2):264-70","ArticleIdList":{"ArticleId":"21094653"}},{"Citation":"Lancet Neurol. 2009 Sep;8(9):791-801","ArticleIdList":{"ArticleId":"19646924"}},{"Citation":"J Neurosci. 2011 Nov 2;31(44):15775-86","ArticleIdList":{"ArticleId":"22049421"}},{"Citation":"Drug Discov Today. 2015 Jan;20(1):50-64","ArticleIdList":{"ArticleId":"25256777"}},{"Citation":"Nat Neurosci. 2014 Aug;17(8):1064-72","ArticleIdList":{"ArticleId":"25017010"}},{"Citation":"IEEE Trans Med Imaging. 2009 Jul;28(7):1023-36","ArticleIdList":{"ArticleId":"19150781"}},{"Citation":"Comput Methods Programs Biomed. 2010 Jun;98(3):278-84","ArticleIdList":{"ArticleId":"19818524"}},{"Citation":"Neuron. 2012 Mar 22;73(6):1216-27","ArticleIdList":{"ArticleId":"22445348"}},{"Citation":"Brain. 2012 Apr;135(Pt 4):1165-79","ArticleIdList":{"ArticleId":"22505631"}},{"Citation":"Hum Brain Mapp. 2015 May;36(5):1728-40","ArticleIdList":{"ArticleId":"25640796"}},{"Citation":"Lancet Neurol. 2011 Jan;10(1):31-42","ArticleIdList":{"ArticleId":"21130037"}},{"Citation":"Mov Disord. 2014 Sep 15;29(11):1434-45","ArticleIdList":{"ArticleId":"25155142"}},{"Citation":"Neuroimage. 2014 Aug 1;96:174-82","ArticleIdList":{"ArticleId":"24699017"}},{"Citation":"J Cogn Neurosci. 2015 Sep;27(9):1801-10","ArticleIdList":{"ArticleId":"25941870"}},{"Citation":"J Neural Transm Suppl. 1998;53:127-40","ArticleIdList":{"ArticleId":"9700651"}},{"Citation":"NMR Biomed. 2013 Dec;26(12):1775-86","ArticleIdList":{"ArticleId":"24038308"}},{"Citation":"Nat Rev Neurosci. 2009 Mar;10(3):186-98","ArticleIdList":{"ArticleId":"19190637"}},{"Citation":"Neuroimage. 2010 Sep;52(3):1059-69","ArticleIdList":{"ArticleId":"19819337"}},{"Citation":"Neuroimage. 2007 Jan 1;34(1):144-55","ArticleIdList":{"ArticleId":"17070705"}},{"Citation":"Neuroimage. 2010 Dec;53(4):1197-207","ArticleIdList":{"ArticleId":"20600983"}},{"Citation":"Neuroimage. 2006 Jul 1;31(3):968-80","ArticleIdList":{"ArticleId":"16530430"}},{"Citation":"J Neurosci. 2008 Jul 9;28(28):7143-52","ArticleIdList":{"ArticleId":"18614684"}},{"Citation":"Mov Disord. 2014 Apr 15;29(5):673-83","ArticleIdList":{"ArticleId":"24757115"}},{"Citation":"JAMA Psychiatry. 2013 Aug;70(8):783-92","ArticleIdList":{"ArticleId":"23739835"}},{"Citation":"Brain. 2008 Jan;131(Pt 1):196-204","ArticleIdList":{"ArticleId":"18056161"}},{"Citation":"Proc Natl Acad Sci U S A. 2012 Jul 10;109(28):11372-7","ArticleIdList":{"ArticleId":"22711833"}},{"Citation":"Acta Neuropathol. 2011 May;121(5):589-95","ArticleIdList":{"ArticleId":"21516512"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2012 Jul;83(7):687-94","ArticleIdList":{"ArticleId":"22566599"}},{"Citation":"PLoS One. 2013;8(2):e53135","ArticleIdList":{"ArticleId":"23405066"}},{"Citation":"J Neurosci. 2012 Mar 21;32(12):4307-18","ArticleIdList":{"ArticleId":"22442092"}},{"Citation":"Mov Disord. 2013 Jan;28(1):31-40","ArticleIdList":{"ArticleId":"23390095"}},{"Citation":"Brain. 2015 Jun;138(Pt 6):1696-709","ArticleIdList":{"ArticleId":"25808370"}},{"Citation":"Neurobiol Dis. 2011 Jun;42(3):475-81","ArticleIdList":{"ArticleId":"21382492"}},{"Citation":"Hum Brain Mapp. 2002 Nov;17(3):143-55","ArticleIdList":{"ArticleId":"12391568"}},{"Citation":"Neuroimage. 2013 Oct 15;80:515-26","ArticleIdList":{"ArticleId":"23623973"}},{"Citation":"Neuroimage. 2015 Apr 1;109:341-56","ArticleIdList":{"ArticleId":"25555998"}},{"Citation":"Neurobiol Aging. 2003 Mar-Apr;24(2):197-211","ArticleIdList":{"ArticleId":"12498954"}},{"Citation":"Nat Med. 2014 May;20(5):536-41","ArticleIdList":{"ArticleId":"24784230"}},{"Citation":"Neurobiol Dis. 2014 May;65:180-7","ArticleIdList":{"ArticleId":"24480090"}},{"Citation":"Front Syst Neurosci. 2011 Jun 16;5:46","ArticleIdList":{"ArticleId":"21720523"}},{"Citation":"Mov Disord. 1996 Mar;11(2):136-42","ArticleIdList":{"ArticleId":"8684382"}},{"Citation":"Front Psychiatry. 2014 Sep 29;5:132","ArticleIdList":{"ArticleId":"25324786"}},{"Citation":"Neuroimage. 2007 May 1;35(4):1459-72","ArticleIdList":{"ArticleId":"17379540"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"25640796","DateCompleted":{"Year":"2015","Month":"12","Day":"31"},"DateRevised":{"Year":"2020","Month":"06","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1097-0193","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"36","Issue":"5","PubDate":{"Year":"2015","Month":"May"}},"Title":"Human brain mapping","ISOAbbreviation":"Hum Brain Mapp"},"ArticleTitle":"Basal ganglia-cortical structural connectivity in Huntington's disease.","Pagination":{"MedlinePgn":"1728-40"},"ELocationID":"10.1002\/hbm.22733","Abstract":{"AbstractText":"Huntington's disease is an incurable neurodegenerative disease caused by inheritance of an expanded cytosine-adenine-guanine (CAG) trinucleotide repeat within the Huntingtin gene. Extensive volume loss and altered diffusion metrics in the basal ganglia, cortex and white matter are seen when patients with Huntington's disease (HD) undergo structural imaging, suggesting that changes in basal ganglia-cortical structural connectivity occur. The aims of this study were to characterise altered patterns of basal ganglia-cortical structural connectivity with high anatomical precision in premanifest and early manifest HD, and to identify associations between structural connectivity and genetic or clinical markers of HD. 3-Tesla diffusion tensor magnetic resonance images were acquired from 14 early manifest HD subjects, 17 premanifest HD subjects and 18 controls. Voxel-based analyses of probabilistic tractography were used to quantify basal ganglia-cortical structural connections. Canonical variate analysis was used to demonstrate disease-associated patterns of altered connectivity and to test for associations between connectivity and genetic and clinical markers of HD; this is the first study in which such analyses have been used. Widespread changes were seen in basal ganglia-cortical structural connectivity in early manifest HD subjects; this has relevance for development of therapies targeting the striatum. Premanifest HD subjects had a pattern of connectivity more similar to that of controls, suggesting progressive change in connections over time. Associations between structural connectivity patterns and motor and cognitive markers of disease severity were present in early manifest subjects. Our data suggest the clinical phenotype in manifest HD may be at least partly a result of altered connectivity.","CopyrightInformation":"\u00a9 2015 Wiley Periodicals, Inc."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Novak","ForeName":"Marianne J U","Initials":"MJ","AffiliationInfo":{"Affiliation":"Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, United Kingdom; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, United Kingdom."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Seunarine","ForeName":"Kiran K","Initials":"KK"},{"@attributes":{"ValidYN":"Y"},"LastName":"Gibbard","ForeName":"Clare R","Initials":"CR"},{"@attributes":{"ValidYN":"Y"},"LastName":"McColgan","ForeName":"Peter","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Draganski","ForeName":"Bogdan","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Friston","ForeName":"Karl","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris A","Initials":"CA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tabrizi","ForeName":"Sarah J","Initials":"SJ"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"G1002276","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"MR\/L02053X\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"088130\/Z\/09\/Z","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"088130","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"},{"GrantID":"MR\/L012936\/1","Acronym":"MRC_","Agency":"Medical Research Council","Country":"United Kingdom"},{"GrantID":"091593","Acronym":"WT_","Agency":"Wellcome Trust","Country":"United Kingdom"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2015","Month":"01","Day":"30"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Hum Brain Mapp","NlmUniqueID":"9419065","ISSNLinking":"1065-9471"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Basal Ganglia","QualifierName":"pathology"},{"DescriptorName":"Corpus Striatum","QualifierName":"pathology"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Huntington Disease","QualifierName":["genetics","pathology"]},{"DescriptorName":"Image Processing, Computer-Assisted"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neural Pathways","QualifierName":"pathology"},{"DescriptorName":"Severity of Illness Index"},{"DescriptorName":"Trinucleotide Repeat Expansion"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Huntington's disease","basal ganglia","connectivity","cortical","diffusion MRI","tractography"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2014","Month":"04","Day":"23"},{"@attributes":{"PubStatus":"revised"},"Year":"2014","Month":"11","Day":"04"},{"@attributes":{"PubStatus":"accepted"},"Year":"2014","Month":"12","Day":"22"},{"@attributes":{"PubStatus":"entrez"},"Year":"2015","Month":"2","Day":"3","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2015","Month":"2","Day":"3","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2016","Month":"1","Day":"1","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["25640796","10.1002\/hbm.22733","PMC6869797"]},"ReferenceList":{"Reference":[{"Citation":"Neuropsychologia. 2010 Jan;48(2):549-57","ArticleIdList":{"ArticleId":"19878688"}},{"Citation":"Mov Disord. 2006 Jul;21(7):1043-7","ArticleIdList":{"ArticleId":"16570300"}},{"Citation":"Brain. 1997 Nov;120 ( Pt 11):2029-38","ArticleIdList":{"ArticleId":"9397019"}},{"Citation":"Neurology. 2010 Apr 13;74(15):1208-16","ArticleIdList":{"ArticleId":"20385893"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2010 Mar;81(3):257-62","ArticleIdList":{"ArticleId":"19237387"}},{"Citation":"Hum Brain Mapp. 1996;4(2):140-51","ArticleIdList":{"ArticleId":"20408193"}},{"Citation":"Brain Imaging Behav. 2009 Mar 1;3(1):77-84","ArticleIdList":{"ArticleId":"21415933"}},{"Citation":"Neurology. 2003 May 27;60(10):1615-20","ArticleIdList":{"ArticleId":"12771251"}},{"Citation":"Hum Brain Mapp. 2013 Sep;34(9):2141-53","ArticleIdList":{"ArticleId":"22438242"}},{"Citation":"PLoS One. 2013;8(2):e53135","ArticleIdList":{"ArticleId":"23405066"}},{"Citation":"Inf Process Med Imaging. 2003 Jul;18:684-95","ArticleIdList":{"ArticleId":"15344498"}},{"Citation":"Lancet Neurol. 2011 Jan;10(1):31-42","ArticleIdList":{"ArticleId":"21130037"}},{"Citation":"Ann Neurol. 1997 May;41(5):689-92","ArticleIdList":{"ArticleId":"9153534"}},{"Citation":"J Clin Invest. 2011 Feb;121(2):500-7","ArticleIdList":{"ArticleId":"21285523"}},{"Citation":"Neurobiol Dis. 2011 Jun;42(3):475-81","ArticleIdList":{"ArticleId":"21382492"}},{"Citation":"Brain. 2008 Jan;131(Pt 1):196-204","ArticleIdList":{"ArticleId":"18056161"}},{"Citation":"AJNR Am J Neuroradiol. 2004 Nov-Dec;25(10):1715-21","ArticleIdList":{"ArticleId":"15569736"}},{"Citation":"Med Image Comput Comput Assist Interv. 2010;13(Pt 2):217-24","ArticleIdList":{"ArticleId":"20879318"}},{"Citation":"Neuroimage. 1995 Jun;2(2):166-72","ArticleIdList":{"ArticleId":"9343599"}},{"Citation":"Neuroimage. 2009 Jul 15;46(4):958-66","ArticleIdList":{"ArticleId":"19332141"}},{"Citation":"J Neuropsychiatry Clin Neurosci. 2005 Summer;17(3):378-83","ArticleIdList":{"ArticleId":"16179661"}},{"Citation":"J Neurol. 2009 Jan;256(1):109-14","ArticleIdList":{"ArticleId":"19267169"}},{"Citation":"AJNR Am J Neuroradiol. 2010 Oct;31(9):1675-81","ArticleIdList":{"ArticleId":"20488902"}},{"Citation":"Brain. 2012 Apr;135(Pt 4):1165-79","ArticleIdList":{"ArticleId":"22505631"}},{"Citation":"Lancet Neurol. 2012 Jan;11(1):42-53","ArticleIdList":{"ArticleId":"22137354"}},{"Citation":"Brain Imaging Behav. 2011 Sep;5(3):171-80","ArticleIdList":{"ArticleId":"21437574"}},{"Citation":"J Neurosci. 2008 Jul 9;28(28):7143-52","ArticleIdList":{"ArticleId":"18614684"}},{"Citation":"J Int Neuropsychol Soc. 2007 Sep;13(5):758-69","ArticleIdList":{"ArticleId":"17697407"}},{"Citation":"Brain. 2004 Jun;127(Pt 6):1446-53","ArticleIdList":{"ArticleId":"15090475"}},{"Citation":"AJNR Am J Neuroradiol. 2010 Apr;31(4):706-10","ArticleIdList":{"ArticleId":"19942704"}},{"Citation":"Exp Neurol. 2013 Jan;239:218-28","ArticleIdList":{"ArticleId":"23123406"}},{"Citation":"Mov Disord. 2006 Sep;21(9):1317-25","ArticleIdList":{"ArticleId":"16755582"}},{"Citation":"Eur J Neurol. 2008 Nov;15(11):1180-90","ArticleIdList":{"ArticleId":"18754766"}},{"Citation":"Mov Disord. 1996 Mar;11(2):136-42","ArticleIdList":{"ArticleId":"8684382"}},{"Citation":"Acta Psychiatr Scand. 1983 Jun;67(6):361-70","ArticleIdList":{"ArticleId":"6880820"}},{"Citation":"J Magn Reson B. 1994 Mar;103(3):247-54","ArticleIdList":{"ArticleId":"8019776"}},{"Citation":"Neuroimage. 2006 Jul 1;31(3):968-80","ArticleIdList":{"ArticleId":"16530430"}},{"Citation":"Exp Neurol. 2009 Apr;216(2):525-9","ArticleIdList":{"ArticleId":"19320010"}},{"Citation":"Brain. 2005 Oct;128(Pt 10):2224-39","ArticleIdList":{"ArticleId":"16141282"}},{"Citation":"Lancet Neurol. 2009 Sep;8(9):791-801","ArticleIdList":{"ArticleId":"19646924"}},{"Citation":"Neuropsychologia. 2008 Apr;46(5):1279-89","ArticleIdList":{"ArticleId":"18221758"}},{"Citation":"Neuroimage. 2004;23 Suppl 1:S208-19","ArticleIdList":{"ArticleId":"15501092"}},{"Citation":"Psychiatry Res. 2005 Oct 30;140(1):55-62","ArticleIdList":{"ArticleId":"16199141"}},{"Citation":"J Neuropathol Exp Neurol. 1985 Nov;44(6):559-77","ArticleIdList":{"ArticleId":"2932539"}},{"Citation":"Neuroimage. 2007 Oct 15;38(1):95-113","ArticleIdList":{"ArticleId":"17761438"}},{"Citation":"Radiology. 2004 Sep;232(3):867-73","ArticleIdList":{"ArticleId":"15215553"}},{"Citation":"Hum Brain Mapp. 2012 Jan;33(1):203-12","ArticleIdList":{"ArticleId":"21264990"}},{"Citation":"Cereb Cortex. 2012 Dec;22(12):2858-66","ArticleIdList":{"ArticleId":"22223853"}},{"Citation":"Neurobiol Dis. 2013 Mar;51:82-92","ArticleIdList":{"ArticleId":"23069680"}},{"Citation":"Neuroimage. 2007 May 1;35(4):1459-72","ArticleIdList":{"ArticleId":"17379540"}},{"Citation":"Exp Neurol. 2008 Sep;213(1):137-44","ArticleIdList":{"ArticleId":"18588876"}},{"Citation":"Child Neuropsychol. 2000 Sep;6(3):235-8","ArticleIdList":{"ArticleId":"11419452"}},{"Citation":"Neurobiol Dis. 2014 May;65:180-7","ArticleIdList":{"ArticleId":"24480090"}},{"Citation":"Neuroimage. 2010 Feb 15;49(4):2995-3004","ArticleIdList":{"ArticleId":"19850138"}},{"Citation":"Neurology. 1994 May;44(5):823-8","ArticleIdList":{"ArticleId":"8190282"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"24405816","DateCompleted":{"Year":"2014","Month":"11","Day":"06"},"DateRevised":{"Year":"2014","Month":"03","Day":"10"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1973-8102","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"52","PubDate":{"Year":"2014","Month":"Mar"}},"Title":"Cortex; a journal devoted to the study of the nervous system and behavior","ISOAbbreviation":"Cortex"},"ArticleTitle":"White matter integrity in premanifest and early Huntington's disease is related to caudate loss and disease progression.","Pagination":{"MedlinePgn":"98-112"},"ELocationID":["10.1016\/j.cortex.2013.11.009","S0010-9452(13)00284-0"],"Abstract":{"AbstractText":["Huntington's disease (HD) is associated with progressive loss of caudate and white matter volume and integrity. Our aim was to systematically assess interactions between these changes and genetic markers of disease progression; we are not aware of previous studies in which this has been explicitly tested.","Tract-based spatial statistics were used to assess: (a) differences between the white matter diffusion metrics (fractional anisotropy and mean diffusivity) of 17 premanifest and 19 early manifest HD gene carriers and 21 controls, and (b) the relationships between diffusion metrics, caudate and total white matter volume, and disease burden score and CAG repeat length. Caudate and total white matter volumes were quantified using FIRST and SIENAX respectively. Multiple regression analysis was used to assess which of the imaging metrics predicted disease severity in the HD subjects.","Diffusion metrics were significantly altered in premanifest and early HD gene carriers in comparison with controls throughout the white matter skeleton. Correlations between diffusion and volumetric metrics and disease progression were also present. Together, caudate volume and mean white matter fractional anisotropy and mean diffusivity predicted disease burden score in the HD subjects.","The diffusion properties of white matter are extensively altered in HD, and are associated with markers of HD severity, and with caudate and white matter volumes. The correlation between diffusion metrics and white matter volume is stronger in HD subjects than in controls, but there is no such significant interaction for the correlation between diffusion and caudate volume: we propose that many of the changes in white matter diffusion in HD occur as a 'normal' physiological response to pathological caudate volume loss. We have defined the extent to which mean white matter fractional anisotropy, white matter volume and caudate volume are associated with disease burden score."],"CopyrightInformation":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Novak","ForeName":"Marianne J U","Initials":"MJ","AffiliationInfo":{"Affiliation":"National Hospital for Neurology and Neurosurgery, London, UK; Wellcome Trust Centre for Neuroimaging, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Seunarine","ForeName":"Kiran K","Initials":"KK","AffiliationInfo":{"Affiliation":"Imaging and Biophysics Unit, UCL Institute of Child Health, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Gibbard","ForeName":"Clare R","Initials":"CR","AffiliationInfo":{"Affiliation":"Imaging and Biophysics Unit, UCL Institute of Child Health, London, UK; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Hobbs","ForeName":"Nicola Z","Initials":"NZ","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Scahill","ForeName":"Rachael I","Initials":"RI","AffiliationInfo":{"Affiliation":"Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris A","Initials":"CA","AffiliationInfo":{"Affiliation":"Imaging and Biophysics Unit, UCL Institute of Child Health, London, UK. Electronic address: christopher.clark@ucl.ac.uk."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tabrizi","ForeName":"Sarah J","Initials":"SJ","AffiliationInfo":{"Affiliation":"National Hospital for Neurology and Neurosurgery, London, UK; Department of Neurodegenerative Disease, UCL Institute of Neurology, London, UK. Electronic address: s.tabrizi@prion.ucl.ac.uk."}}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":{"GrantID":"091593\/Z\/10\/Z","Agency":"Wellcome Trust","Country":"United Kingdom"}},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2013","Month":"12","Day":"06"}},"MedlineJournalInfo":{"Country":"Italy","MedlineTA":"Cortex","NlmUniqueID":"0100725","ISSNLinking":"0010-9452"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Atrophy","QualifierName":"pathology"},{"DescriptorName":"Caudate Nucleus","QualifierName":"pathology"},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Huntington Disease","QualifierName":"pathology"},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Nerve Fibers, Myelinated","QualifierName":"pathology"},{"DescriptorName":"Neuroimaging"},{"DescriptorName":"Organ Size"}]},"KeywordList":{"@attributes":{"Owner":"NOTNLM"},"Keyword":["Caudate","DTI (diffusion tensor imaging)","Diffusion","Huntington's disease","TBSS (tract-based spatial statistics)"]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2013","Month":"03","Day":"17"},{"@attributes":{"PubStatus":"revised"},"Year":"2013","Month":"08","Day":"26"},{"@attributes":{"PubStatus":"accepted"},"Year":"2013","Month":"11","Day":"25"},{"@attributes":{"PubStatus":"entrez"},"Year":"2014","Month":"1","Day":"11","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2014","Month":"1","Day":"11","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2014","Month":"11","Day":"7","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["24405816","S0010-9452(13)00284-0","10.1016\/j.cortex.2013.11.009"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"21624563","DateCompleted":{"Year":"2011","Month":"09","Day":"16"},"DateRevised":{"Year":"2019","Month":"12","Day":"10"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1558-4623","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"41","Issue":"4","PubDate":{"Year":"2011","Month":"Jul"}},"Title":"Seminars in nuclear medicine","ISOAbbreviation":"Semin Nucl Med"},"ArticleTitle":"Florbetapir f-18: a histopathologically validated Beta-amyloid positron emission tomography imaging agent.","Pagination":{"MedlinePgn":"300-4"},"ELocationID":"10.1053\/j.semnuclmed.2011.03.001","Abstract":{"AbstractText":"Florbetapir F-18 is a molecular imaging agent combining high affinity for \u03b2-amyloid, pharmacokinetic properties that allow positron emission tomography (PET) imaging within a convenient time after dose administration, and the wide availability of the radionuclide fluorine-18. Florbetapir F-18 is prepared by nucleophilic radiofluorination in approximately 60 minutes with a decay-corrected yield of 20%-40% and with a specific activity typically exceeding 100 Ci\/mmol. The florbetapir F-18 dissociation constant (K(d)) for binding to \u03b2-amyloid in brain tissue from Alzheimer's disease (AD) patients was 3.7 \u00b1 0.3 nmol\/L, and the maximum binding capacity (B(max)) was 8800 \u00b1 1600 fmol\/mg protein. Autoradiography studies have shown that florbetapir F-18 selectively binds to \u03b2-amyloid aggregates in AD patient brain tissue, and the binding intensity is correlated with the density of \u03b2-amyloid quantified by standard neuropathologic techniques. Studies in animals revealed no safety concerns and rapid and transient normal brain uptake (6.8% injected dose\/g at 2 minutes and 1.9% injected dose\/g at 60 minutes in the mouse). Florbetapir F-18 has been well-tolerated in studies of more than 2000 human subjects. Biodistribution studies in humans revealed predominantly hepatobiliary excretion. The whole body effective dose was 7 mSv from a dose of 370 MBq. The pharmacokinetic of florbetapir F-18 make it possible to obtain a PET image with a brief (10 minutes) acquisition time within a convenient time window of 30-90 minutes after dose administration. Clinical studies have demonstrated a clear correlation between in vivo PET imaging with florbetapir F-18 and postmortem histopathologic quantitation of \u03b2-amyloid in the brain.","CopyrightInformation":"Copyright \u00a9 2011 Elsevier Inc. All rights reserved."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Lister-James","ForeName":"John","Initials":"J","AffiliationInfo":{"Affiliation":"Avid Radiopharmaceuticals, Philadelphia, PA. listerjames@avidrp.com"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Pontecorvo","ForeName":"Michael J","Initials":"MJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Joshi","ForeName":"Abhinay D","Initials":"AD"},{"@attributes":{"ValidYN":"Y"},"LastName":"Mintun","ForeName":"Mark A","Initials":"MA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zhang","ForeName":"Wei","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lim","ForeName":"Nathaniel","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zhuang","ForeName":"Zhiping","Initials":"Z"},{"@attributes":{"ValidYN":"Y"},"LastName":"Golding","ForeName":"Geoff","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Choi","ForeName":"Seok Rye","Initials":"SR"},{"@attributes":{"ValidYN":"Y"},"LastName":"Benedum","ForeName":"Tyler E","Initials":"TE"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kennedy","ForeName":"Paul","Initials":"P"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hefti","ForeName":"Franz","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Carpenter","ForeName":"Alan P","Initials":"AP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kung","ForeName":"Hank F","Initials":"HF"},{"@attributes":{"ValidYN":"Y"},"LastName":"Skovronsky","ForeName":"Daniel M","Initials":"DM"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Validation Study"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Semin Nucl Med","NlmUniqueID":"1264464","ISSNLinking":"0001-2998"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Amyloid beta-Peptides"},{"RegistryNumber":"0","NameOfSubstance":"Aniline Compounds"},{"RegistryNumber":"0","NameOfSubstance":"Ethylene Glycols"},{"RegistryNumber":"0","NameOfSubstance":"Radiopharmaceuticals"},{"RegistryNumber":"6867Q6IKOD","NameOfSubstance":"florbetapir"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnostic imaging","metabolism","pathology"]},{"DescriptorName":"Amyloid beta-Peptides","QualifierName":"metabolism"},{"DescriptorName":"Aniline Compounds","QualifierName":["chemistry","pharmacokinetics"]},{"DescriptorName":"Animals"},{"DescriptorName":"Cerebral Cortex","QualifierName":["diagnostic imaging","metabolism","pathology"]},{"DescriptorName":"Dogs"},{"DescriptorName":"Ethylene Glycols","QualifierName":["chemistry","pharmacokinetics"]},{"DescriptorName":"Humans"},{"DescriptorName":"Mice"},{"DescriptorName":"Molecular Imaging"},{"DescriptorName":"Positron-Emission Tomography","QualifierName":"methods"},{"DescriptorName":"Radiopharmaceuticals","QualifierName":["chemistry","pharmacokinetics"]},{"DescriptorName":"Rats"},{"DescriptorName":"Tissue Distribution"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2011","Month":"6","Day":"1","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2011","Month":"6","Day":"1","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2011","Month":"9","Day":"17","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["21624563","S0001-2998(11)00035-3","10.1053\/j.semnuclmed.2011.03.001"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"21097123","DateCompleted":{"Year":"2011","Month":"03","Day":"11"},"DateRevised":{"Year":"2020","Month":"09","Day":"28"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"2375-7477","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"2010","PubDate":{"Year":"2010"}},"Title":"Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference","ISOAbbreviation":"Annu Int Conf IEEE Eng Med Biol Soc"},"ArticleTitle":"Multimodal EEG, MRI and PET data fusion for Alzheimer's disease diagnosis.","Pagination":{"MedlinePgn":"6058-61"},"ELocationID":"10.1109\/IEMBS.2010.5627621","Abstract":{"AbstractText":"Alarmingly increasing prevalence of Alzheimer's disease (AD) due to the aging population in developing countries, combined with lack of standardized and conclusive diagnostic procedures, make early diagnosis of Alzheimer's disease a major public health concern. While no current medical treatment exists to stop or reverse this disease, recent dementia specific pharmacological advances can slow its progression, making early diagnosis all the more important. Several noninvasive biomarkers have been proposed, including P300 based EEG analysis, MRI volumetric analysis, PET based metabolic activity analysis, as alternatives to neuropsychological evaluation, the current gold standard of diagnosis. Each of these approaches, have shown some promising outcomes, however, a comprehensive data fusion analysis has not yet been conducted to investigate whether these different modalities carry complementary information, and if so, whether they can be combined to provide a more accurate analysis. In this effort, we provide a first look at such an analysis in combining EEG, MRI and PET data using an ensemble of classifiers based decision fusion approach, to determine whether a strategic combination of these different modalities can improve the diagnostic accuracy over any of the individual data sources when used with an automated classifier. Results show an improvement of up to 10%-20% using this approach compared to the classification performance obtained when using each individual data source."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Polikar","ForeName":"Robi","Initials":"R","AffiliationInfo":{"Affiliation":"Electrical and Computer Eng., Dept. at Rowan University, Glassboro, NJ 08028, USA. polikar@rowan.edu"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Tilley","ForeName":"Christopher","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hillis","ForeName":"Brendan","Initials":"B"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris M","Initials":"CM"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"AG022272","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG10124","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't","Research Support, U.S. Gov't, Non-P.H.S."]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Annu Int Conf IEEE Eng Med Biol Soc","NlmUniqueID":"101763872","ISSNLinking":"2375-7477"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Alzheimer Disease","QualifierName":["diagnosis","diagnostic imaging"]},{"DescriptorName":"Decision Support Systems, Clinical"},{"DescriptorName":"Electrodes"},{"DescriptorName":"Electroencephalography","QualifierName":"methods"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Image Interpretation, Computer-Assisted","QualifierName":"methods"},{"DescriptorName":"Magnetic Resonance Imaging","QualifierName":"methods"},{"DescriptorName":"Male"},{"DescriptorName":"Positron-Emission Tomography","QualifierName":"methods"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2010","Month":"11","Day":"25","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2010","Month":"11","Day":"26","Hour":"6","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2011","Month":"3","Day":"12","Hour":"6","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["21097123","10.1109\/IEMBS.2010.5627621"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"19204154","DateCompleted":{"Year":"2009","Month":"04","Day":"09"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1538-3687","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"66","Issue":"2","PubDate":{"Year":"2009","Month":"Feb"}},"Title":"Archives of neurology","ISOAbbreviation":"Arch Neurol"},"ArticleTitle":"Clinical and pathological continuum of multisystem TDP-43 proteinopathies.","Pagination":{"MedlinePgn":"180-9"},"ELocationID":"10.1001\/archneurol.2008.558","Abstract":{"AbstractText":["To determine the extent of transactivation response DNA-binding protein with a molecular weight of 43 kDa (TDP-43) pathology in the central nervous system of patients with clinically and autopsy-confirmed diagnoses of frontotemporal lobar degeneration with and without motor neuron disease and amyotrophic lateral sclerosis with and without cognitive impairment.","Performance of immunohistochemical whole-central nervous system scans for evidence of pathological TDP-43 and retrospective clinical medical record review.","An academic medical center.","We included 64 patients with clinically and pathologically confirmed frontotemporal lobar degeneration with ubiquitinated inclusions with or without motor neuron disease and amyotrophic lateral sclerosis with or without cognitive impairment.","Neuronal and glial TDP-43 pathology.","We found evidence of neuronal and glial TDP-43 pathology in all disease groups throughout the neuraxis, albeit with variations in the frequency, morphology, and distribution of TDP-43 lesions. Moreover, the major clinical manifestations (eg, cognitive impairments, motor neuron signs, extrapyramidal symptoms, neuropsychiatric features) were reflected by the predominant distribution and burden of TDP-43 pathology.","These findings strongly suggest that amyotrophic lateral sclerosis, frontotemporal lobar degeneration with amyotrophic lateral sclerosis or motor neuron disease, and frontotemporal lobar degeneration with ubiquitinated inclusions are different manifestations of a multiple-system TDP-43 proteinopathy linked to similar mechanisms of neurodegeneration."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Geser","ForeName":"Felix","Initials":"F","AffiliationInfo":{"Affiliation":"Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104-4283, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Martinez-Lage","ForeName":"Maria","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Robinson","ForeName":"John","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Uryu","ForeName":"Kunihiro","Initials":"K"},{"@attributes":{"ValidYN":"Y"},"LastName":"Neumann","ForeName":"Manuela","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Brandmeir","ForeName":"Nicholas J","Initials":"NJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Xie","ForeName":"Sharon X","Initials":"SX"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kwong","ForeName":"Linda K","Initials":"LK"},{"@attributes":{"ValidYN":"Y"},"LastName":"Elman","ForeName":"Lauren","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"McCluskey","ForeName":"Leo","Initials":"L"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris M","Initials":"CM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Malunda","ForeName":"Joe","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Miller","ForeName":"Bruce L","Initials":"BL"},{"@attributes":{"ValidYN":"Y"},"LastName":"Zimmerman","ForeName":"Earl A","Initials":"EA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Qian","ForeName":"Jiang","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Deerlin","ForeName":"Vivianna","Initials":"V"},{"@attributes":{"ValidYN":"Y"},"LastName":"Grossman","ForeName":"Murray","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lee","ForeName":"Virginia M-Y","Initials":"VM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Trojanowski","ForeName":"John Q","Initials":"JQ"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"P30 AG010124","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG10124","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P01 AG017586","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P01 AG019724","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG17586","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"HL071483","Acronym":"HL","Agency":"NHLBI NIH HHS","Country":"United States"},{"GrantID":"T35 HL071483","Acronym":"HL","Agency":"NHLBI NIH HHS","Country":"United States"},{"GrantID":"P01 AG017586-09","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural"]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Arch Neurol","NlmUniqueID":"0372436","ISSNLinking":"0003-9942"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"DNA-Binding Proteins"},{"RegistryNumber":"0","NameOfSubstance":"Ubiquitin"}]},"CitationSubset":["AIM","IM"],"MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Amyotrophic Lateral Sclerosis","QualifierName":["pathology","physiopathology"]},{"DescriptorName":"Brain","QualifierName":["pathology","physiopathology"]},{"DescriptorName":"Brain Mapping"},{"DescriptorName":"Cognition Disorders","QualifierName":["etiology","pathology","physiopathology"]},{"DescriptorName":"DNA-Binding Proteins","QualifierName":["analysis","metabolism"]},{"DescriptorName":"Dementia","QualifierName":["pathology","physiopathology"]},{"DescriptorName":"Disease Progression"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Immunohistochemistry"},{"DescriptorName":"Inclusion Bodies","QualifierName":["metabolism","pathology"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Motor Neuron Disease","QualifierName":["pathology","physiopathology"]},{"DescriptorName":"Movement Disorders","QualifierName":["etiology","pathology","physiopathology"]},{"DescriptorName":"Neuroglia","QualifierName":["metabolism","pathology"]},{"DescriptorName":"Neurons","QualifierName":["metabolism","pathology"]},{"DescriptorName":"Retrospective Studies"},{"DescriptorName":"Ubiquitin","QualifierName":["analysis","metabolism"]},{"DescriptorName":"Ubiquitination"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"entrez"},"Year":"2009","Month":"2","Day":"11","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2009","Month":"2","Day":"11","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2009","Month":"4","Day":"10","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["19204154","66\/2\/180","10.1001\/archneurol.2008.558","PMC2774117","NIHMS107108"]},"ReferenceList":{"Reference":[{"Citation":"Amyotroph Lateral Scler Other Motor Neuron Disord. 2000 Dec;1(5):293-9","ArticleIdList":{"ArticleId":"11464847"}},{"Citation":"Neurology. 1998 Dec;51(6):1546-54","ArticleIdList":{"ArticleId":"9855500"}},{"Citation":"J Neuropathol Exp Neurol. 2005 Aug;64(8):730-9","ArticleIdList":{"ArticleId":"16106222"}},{"Citation":"Neurology. 2006 Mar 28;66(6):839-44","ArticleIdList":{"ArticleId":"16421333"}},{"Citation":"Am J Pathol. 2006 Oct;169(4):1343-52","ArticleIdList":{"ArticleId":"17003490"}},{"Citation":"Science. 2006 Oct 6;314(5796):130-3","ArticleIdList":{"ArticleId":"17023659"}},{"Citation":"Acta Neuropathol. 2006 Nov;112(5):539-49","ArticleIdList":{"ArticleId":"17021754"}},{"Citation":"Acta Neuropathol. 2007 May;113(5):521-33","ArticleIdList":{"ArticleId":"17219193"}},{"Citation":"Acta Neuropathol. 2007 Jul;114(1):5-22","ArticleIdList":{"ArticleId":"17579875"}},{"Citation":"Arch Neurol. 2007 Oct;64(10):1449-54","ArticleIdList":{"ArticleId":"17923628"}},{"Citation":"Acta Neuropathol. 2008 Jan;115(1):123-31","ArticleIdList":{"ArticleId":"18004574"}},{"Citation":"Neurosignals. 2008;16(1):41-51","ArticleIdList":{"ArticleId":"18097159"}},{"Citation":"Hum Mol Genet. 2008 May 15;17(10):1349-62","ArticleIdList":{"ArticleId":"18223198"}},{"Citation":"Arch Neurol. 2008 May;65(5):636-41","ArticleIdList":{"ArticleId":"18474740"}},{"Citation":"Acta Neuropathol. 2008 Aug;116(2):169-82","ArticleIdList":{"ArticleId":"18481073"}},{"Citation":"Neurology. 2008 Jul 22;71(4):253-9","ArticleIdList":{"ArticleId":"18184915"}},{"Citation":"J Neuropathol Exp Neurol. 2008 Jul;67(7):635-48","ArticleIdList":{"ArticleId":"18596549"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"18436880","DateCompleted":{"Year":"2008","Month":"07","Day":"23"},"DateRevised":{"Year":"2016","Month":"11","Day":"22"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1524-4628","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"39","Issue":"7","PubDate":{"Year":"2008","Month":"Jul"}},"Title":"Stroke","ISOAbbreviation":"Stroke"},"ArticleTitle":"Multimodal MRI in cerebral small vessel disease: its relationship with cognition and sensitivity to change over time.","Pagination":{"MedlinePgn":"1999-2005"},"ELocationID":"10.1161\/STROKEAHA.107.507475","Abstract":{"AbstractText":["Cerebral small vessel disease is the most common cause of vascular dementia. Interest in using MRI parameters as surrogate markers of disease to assess therapies is increasing. In patients with symptomatic sporadic small vessel disease, we determined which MRI parameters best correlated with cognitive function on cross-sectional analysis and which changed over a period of 1 year.","Thirty-five patients with lacunar stroke and leukoaraiosis were recruited. They underwent multimodal MRI (brain volume, fluid-attenuated inversion recovery lesion load, lacunar infarct number, fractional anisotropy, and mean diffusivity from diffusion tensor imaging) and neuropsychological testing. Twenty-seven agreed to reattend for repeat MRI and neuropsychology at 1 year.","An executive function score correlated most strongly with diffusion tensor imaging (fractional anisotropy histogram, r=-0.640, P=0.004) and brain volume (r=0.501, P=0.034). Associations with diffusion tensor imaging were stronger than with all other MRI parameters. On multiple regression of all imaging parameters, a model that contained brain volume and fractional anisotropy, together with age, gender, and premorbid IQ, explained 74% of the variance of the executive function score (P=0.0001). Changes in mean diffusivity and fractional anisotropy were detectable over the 1-year follow-up; in contrast, no change in other MRI parameters was detectable over this time period.","A multimodal MRI model explains a large proportion of the variation in executive function in cerebral small vessel disease. In particular, diffusion tensor imaging correlates best with executive function and is the most sensitive to change. This supports the use of MRI, in particular diffusion tensor imaging, as a surrogate marker in treatment trials."]},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Nitkunan","ForeName":"Arani","Initials":"A","AffiliationInfo":{"Affiliation":"Centre for Clinical Neuroscience, St George's, University of London, Cranmer Terrace, London SW17 0RE, UK."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Barrick","ForeName":"Tom R","Initials":"TR"},{"@attributes":{"ValidYN":"Y"},"LastName":"Charlton","ForeName":"Rebecca A","Initials":"RA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris A","Initials":"CA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Markus","ForeName":"Hugh S","Initials":"HS"}]},"Language":"eng","PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2008","Month":"04","Day":"24"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Stroke","NlmUniqueID":"0235266","ISSNLinking":"0039-2499"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Brain Diseases","QualifierName":["diagnosis","pathology"]},{"DescriptorName":"Brain Infarction","QualifierName":["diagnosis","pathology"]},{"DescriptorName":"Brain Ischemia","QualifierName":["diagnosis","pathology"]},{"DescriptorName":"Dementia, Vascular","QualifierName":"etiology"},{"DescriptorName":"Diffusion Magnetic Resonance Imaging","QualifierName":"methods"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Leukoaraiosis","QualifierName":["diagnosis","pathology"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Regression Analysis"},{"DescriptorName":"Reproducibility of Results"},{"DescriptorName":"Time Factors"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2008","Month":"4","Day":"26","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2008","Month":"7","Day":"24","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2008","Month":"4","Day":"26","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["18436880","STROKEAHA.107.507475","10.1161\/STROKEAHA.107.507475"]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"18430993","DateCompleted":{"Year":"2008","Month":"08","Day":"07"},"DateRevised":{"Year":"2019","Month":"11","Day":"10"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"1387-2877","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"13","Issue":"3","PubDate":{"Year":"2008","Month":"Apr"}},"Title":"Journal of Alzheimer's disease : JAD","ISOAbbreviation":"J Alzheimers Dis"},"ArticleTitle":"Multiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.","Pagination":{"MedlinePgn":"255-66"},"Abstract":{"AbstractText":"The epsilon4 allele of the apolipoprotein E gene (APOE) is associated with increased risk and earlier age at onset in late onset Alzheimer's disease (AD). Other factors, such as expression level of apolipoprotein E protein (apoE), have been postulated to modify the APOE related risk of developing AD. Multiple loci in and outside of APOE are associated with a high risk of AD. The aim of this exploratory hypothesis generating investigation was to determine if some of these loci predict cerebrospinal fluid (CSF) apoE levels in healthy non-demented subjects. CSF apoE levels were measured from healthy non-demented subjects 21-87 years of age (n=134). Backward regression models were used to evaluate the influence of 21 SNPs, within and surrounding APOE, on CSF apoE levels while taking into account age, gender, APOE epsilon4 and correlation between SNPs (linkage disequilibrium). APOE epsilon4 genotype does not predict CSF apoE levels. Three SNPs within the TOMM40 gene, one APOE promoter SNP and two SNPs within distal APOE enhancer elements (ME1 and BCR) predict CSF apoE levels. Further investigation of the genetic influence of these loci on apoE expression levels in the central nervous system is likely to provide new insight into apoE regulation as well as AD pathogenesis."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Bekris","ForeName":"Lynn M","Initials":"LM","AffiliationInfo":{"Affiliation":"Geriatric Research, Education, and Clinical Center (GRECC), VA Puget Sound Health Care System, Seattle, WA 98108, USA. lbekris@u.washington.edu"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Millard","ForeName":"Steven P","Initials":"SP"},{"@attributes":{"ValidYN":"Y"},"LastName":"Galloway","ForeName":"Nichole M","Initials":"NM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Vuletic","ForeName":"Simona","Initials":"S"},{"@attributes":{"ValidYN":"Y"},"LastName":"Albers","ForeName":"John J","Initials":"JJ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Li","ForeName":"Ge","Initials":"G"},{"@attributes":{"ValidYN":"Y"},"LastName":"Galasko","ForeName":"Douglas R","Initials":"DR"},{"@attributes":{"ValidYN":"Y"},"LastName":"DeCarli","ForeName":"Charles","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"LastName":"Farlow","ForeName":"Martin R","Initials":"MR"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris M","Initials":"CM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Quinn","ForeName":"Joseph F","Initials":"JF"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kaye","ForeName":"Jeffrey A","Initials":"JA"},{"@attributes":{"ValidYN":"Y"},"LastName":"Schellenberg","ForeName":"Gerard D","Initials":"GD"},{"@attributes":{"ValidYN":"Y"},"LastName":"Tsuang","ForeName":"Debby","Initials":"D"},{"@attributes":{"ValidYN":"Y"},"LastName":"Peskind","ForeName":"Elaine R","Initials":"ER"},{"@attributes":{"ValidYN":"Y"},"LastName":"Yu","ForeName":"Chang-En","Initials":"CE"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"P50 AG005136-25","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P01 HL030086","Acronym":"HL","Agency":"NHLBI NIH HHS","Country":"United States"},{"GrantID":"T32 AG000258","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"5T32AG000258-07","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P01HL30086","Acronym":"HL","Agency":"NHLBI NIH HHS","Country":"United States"},{"GrantID":"U01 AG016976","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R21 AG24486-01","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P50 AG005136","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R01 NS48595","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P30 AG010129-18","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P30 AG008017","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R21 AG024486","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG05136","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R01 NS048595","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P30 AG010129","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG08017","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't","Research Support, U.S. Gov't, Non-P.H.S."]}},"MedlineJournalInfo":{"Country":"Netherlands","MedlineTA":"J Alzheimers Dis","NlmUniqueID":"9814863","ISSNLinking":"1387-2877"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Apolipoprotein E4"},{"RegistryNumber":"0","NameOfSubstance":"Apolipoproteins E"},{"RegistryNumber":"0","NameOfSubstance":"DNA Primers"},{"RegistryNumber":"0","NameOfSubstance":"Membrane Transport Proteins"},{"RegistryNumber":"0","NameOfSubstance":"TOMM40 protein, human"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Alzheimer Disease","QualifierName":["cerebrospinal fluid","genetics"]},{"DescriptorName":"Apolipoprotein E4","QualifierName":"genetics"},{"DescriptorName":"Apolipoproteins E","QualifierName":"cerebrospinal fluid"},{"DescriptorName":"DNA Primers","QualifierName":"genetics"},{"DescriptorName":"Enhancer Elements, Genetic"},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Linkage Disequilibrium","QualifierName":"genetics"},{"DescriptorName":"Male"},{"DescriptorName":"Membrane Transport Proteins","QualifierName":"genetics"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Polymorphism, Single Nucleotide","QualifierName":"genetics"},{"DescriptorName":"Promoter Regions, Genetic"},{"DescriptorName":"Severity of Illness Index"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2008","Month":"4","Day":"24","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2008","Month":"8","Day":"8","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2008","Month":"4","Day":"24","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["18430993","PMC3192652","NIHMS238119","10.3233\/jad-2008-13303"]},"ReferenceList":{"Reference":[{"Citation":"Biochem Biophys Res Commun. 1997 Nov 26;240(3):715-20","ArticleIdList":{"ArticleId":"9398632"}},{"Citation":"Neuroreport. 1999 Mar 17;10(4):879-82","ArticleIdList":{"ArticleId":"10208564"}},{"Citation":"Ann N Y Acad Sci. 1996 Dec 16;802:1-5","ArticleIdList":{"ArticleId":"8993478"}},{"Citation":"Am J Hum Genet. 2000 Aug;67(2):383-94","ArticleIdList":{"ArticleId":"10869235"}},{"Citation":"Am J Hum Genet. 1988 Jan;42(1):104-12","ArticleIdList":{"ArticleId":"3337104"}},{"Citation":"Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5644-51","ArticleIdList":{"ArticleId":"16567625"}},{"Citation":"Neuroreport. 1994 Dec 20;5(18):2534-6","ArticleIdList":{"ArticleId":"7696597"}},{"Citation":"Nat Genet. 1998 Jan;18(1):69-71","ArticleIdList":{"ArticleId":"9425904"}},{"Citation":"Alzheimer Dis Assoc Disord. 1998 Sep;12(3):198-203","ArticleIdList":{"ArticleId":"9772023"}},{"Citation":"Neuroscience. 2003;121(2):315-25","ArticleIdList":{"ArticleId":"14521991"}},{"Citation":"J Biol Chem. 1998 Aug 21;273(34):21800-7","ArticleIdList":{"ArticleId":"9705318"}},{"Citation":"Hum Genet. 1995 Jan;95(1):39-42","ArticleIdList":{"ArticleId":"7814023"}},{"Citation":"Biochim Biophys Acta. 2004 Jan 5;1676(1):41-50","ArticleIdList":{"ArticleId":"14732489"}},{"Citation":"Clin Chem Lab Med. 2007;45(5):592-8","ArticleIdList":{"ArticleId":"17484618"}},{"Citation":"J Biol Chem. 1993 Apr 15;268(11):8221-9","ArticleIdList":{"ArticleId":"7681840"}},{"Citation":"Mol Neurodegener. 2007 Apr 12;2:7","ArticleIdList":{"ArticleId":"17430597"}},{"Citation":"Brain Res. 2002 Feb 22;928(1-2):96-105","ArticleIdList":{"ArticleId":"11844476"}},{"Citation":"J Biol Chem. 2000 Oct 13;275(41):31567-72","ArticleIdList":{"ArticleId":"10893248"}},{"Citation":"Atherosclerosis. 2000 Oct;152(2):475-88","ArticleIdList":{"ArticleId":"10998477"}},{"Citation":"Psychiatr Genet. 2005 Dec;15(4):271-5","ArticleIdList":{"ArticleId":"16314757"}},{"Citation":"Clin Biochem. 1998 Jul;31(5):409-15","ArticleIdList":{"ArticleId":"9721442"}},{"Citation":"Neuroreport. 2005 Jun 21;16(9):1027-30","ArticleIdList":{"ArticleId":"15931082"}},{"Citation":"Am J Hum Genet. 2002 Sep;71(3):501-17","ArticleIdList":{"ArticleId":"12165926"}},{"Citation":"J Neurosci. 2006 Aug 30;26(35):9057-68","ArticleIdList":{"ArticleId":"16943564"}},{"Citation":"Curr Psychiatry Rep. 2000 Apr;2(2):158-64","ArticleIdList":{"ArticleId":"11122949"}},{"Citation":"Neuroscience. 2003;122(2):305-15","ArticleIdList":{"ArticleId":"14614898"}},{"Citation":"Mol Psychiatry. 2002;7(8):886-90","ArticleIdList":{"ArticleId":"12232782"}},{"Citation":"J Cell Biol. 2003 Apr 14;161(1):41-54","ArticleIdList":{"ArticleId":"12695498"}},{"Citation":"Neurosci Lett. 1998 Aug 14;252(2):95-8","ArticleIdList":{"ArticleId":"9756330"}},{"Citation":"J Cell Biol. 2005 Nov 7;171(3):419-23","ArticleIdList":{"ArticleId":"16260501"}},{"Citation":"Dementia. 1996 Sep-Oct;7(5):273-8","ArticleIdList":{"ArticleId":"8872419"}},{"Citation":"Arch Neurol. 2006 Jul;63(7):936-9","ArticleIdList":{"ArticleId":"16831961"}},{"Citation":"J Biol Chem. 1995 Nov 3;270(44):26278-81","ArticleIdList":{"ArticleId":"7592836"}},{"Citation":"Biochim Biophys Acta. 1987 Jan 13;917(1):148-61","ArticleIdList":{"ArticleId":"3539206"}},{"Citation":"J Lipid Res. 2006 Jun;47(6):1298-306","ArticleIdList":{"ArticleId":"16528057"}},{"Citation":"Exp Neurol. 2003 Sep;183(1):249-53","ArticleIdList":{"ArticleId":"12957508"}},{"Citation":"Arch Neurol. 2004 Dec;61(12):1930-4","ArticleIdList":{"ArticleId":"15596614"}},{"Citation":"Am J Med Genet. 2002 Apr 8;114(3):288-91","ArticleIdList":{"ArticleId":"11920850"}},{"Citation":"J Mol Neurosci. 2004;23(3):189-204","ArticleIdList":{"ArticleId":"15181247"}},{"Citation":"J Clin Invest. 1991 Jul;88(1):270-81","ArticleIdList":{"ArticleId":"2056122"}},{"Citation":"FEBS Lett. 1998 Jan 9;421(2):105-8","ArticleIdList":{"ArticleId":"9468288"}},{"Citation":"J Neurosci Res. 2002 May 1;68(3):331-6","ArticleIdList":{"ArticleId":"12111863"}},{"Citation":"Genomics. 2007 Jun;89(6):655-65","ArticleIdList":{"ArticleId":"17434289"}},{"Citation":"J Biol Chem. 2002 Aug 30;277(35):31900-8","ArticleIdList":{"ArticleId":"12032151"}},{"Citation":"Neurosci Lett. 1996 Jul 12;212(2):91-4","ArticleIdList":{"ArticleId":"8832646"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"18223198","DateCompleted":{"Year":"2008","Month":"06","Day":"23"},"DateRevised":{"Year":"2018","Month":"12","Day":"01"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1460-2083","JournalIssue":{"@attributes":{"CitedMedium":"Internet"},"Volume":"17","Issue":"10","PubDate":{"Year":"2008","Month":"May","Day":"15"}},"Title":"Human molecular genetics","ISOAbbreviation":"Hum Mol Genet"},"ArticleTitle":"Variations in the progranulin gene affect global gene expression in frontotemporal lobar degeneration.","Pagination":{"MedlinePgn":"1349-62"},"ELocationID":"10.1093\/hmg\/ddn023","Abstract":{"AbstractText":"Frontotemporal lobar degeneration is a fatal neurodegenerative disease that results in progressive decline in behavior, executive function and sometimes language. Disease mechanisms remain poorly understood. Recently, however, the DNA- and RNA-binding protein TDP-43 has been identified as the major protein present in the hallmark inclusion bodies of frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U), suggesting a role for transcriptional dysregulation in FTLD-U pathophysiology. Using the Affymetrix U133A microarray platform, we profiled global gene expression in both histopathologically affected and unaffected areas of human FTLD-U brains. We then characterized differential gene expression with biological pathway analyses, cluster and principal component analyses, and subgroup analyses based on brain region and progranulin (GRN) gene status. Comparing 17 FTLD-U brains to 11 controls, we identified 414 upregulated and 210 downregulated genes in frontal cortex (P-value < 0.001). Moreover, cluster and principal component analyses revealed that samples with mutations or possibly pathogenic variations in the GRN gene (GRN+, 7\/17) had an expression signature that was distinct from both normal controls and FTLD-U samples lacking GRN gene variations (GRN-, 10\/17). Within the subgroup of GRN+ FTLD-U, we found >1300 dysregulated genes in frontal cortex (P-value < 0.001), many participating in pathways uniquely dysregulated in the GRN+ cases. Our findings demonstrate a distinct molecular phenotype for GRN+ FTLD-U, not readily apparent on clinical or histopathological examination, suggesting distinct pathophysiological mechanisms for GRN+ and GRN- subtypes of FTLD-U. In addition, these data from a large number of human brains provide a valuable resource for future testing of disease hypotheses."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Chen-Plotkin","ForeName":"Alice S","Initials":"AS","AffiliationInfo":{"Affiliation":"Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Geser","ForeName":"Felix","Initials":"F"},{"@attributes":{"ValidYN":"Y"},"LastName":"Plotkin","ForeName":"Joshua B","Initials":"JB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris M","Initials":"CM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Kwong","ForeName":"Linda K","Initials":"LK"},{"@attributes":{"ValidYN":"Y"},"LastName":"Yuan","ForeName":"Wuxing","Initials":"W"},{"@attributes":{"ValidYN":"Y"},"LastName":"Grossman","ForeName":"Murray","Initials":"M"},{"@attributes":{"ValidYN":"Y"},"LastName":"Van Deerlin","ForeName":"Vivianna M","Initials":"VM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Trojanowski","ForeName":"John Q","Initials":"JQ"},{"@attributes":{"ValidYN":"Y"},"LastName":"Lee","ForeName":"Virginia M-Y","Initials":"VM"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"R01 NS044266","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"R01 AG015116","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG10124","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"NS44266","Acronym":"NS","Agency":"NINDS NIH HHS","Country":"United States"},{"GrantID":"P01 AG017586","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG15116","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"P01 AG019724","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG17586","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG023501","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"AG19724","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2008","Month":"01","Day":"25"}},"MedlineJournalInfo":{"Country":"England","MedlineTA":"Hum Mol Genet","NlmUniqueID":"9208958","ISSNLinking":"0964-6906"},"ChemicalList":{"Chemical":[{"RegistryNumber":"0","NameOfSubstance":"Intercellular Signaling Peptides and Proteins"},{"RegistryNumber":"0","NameOfSubstance":"Progranulins"}]},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Brain","QualifierName":"physiopathology"},{"DescriptorName":"Case-Control Studies"},{"DescriptorName":"Cluster Analysis"},{"DescriptorName":"Dementia","QualifierName":["genetics","physiopathology"]},{"DescriptorName":"Female"},{"DescriptorName":"Gene Expression Profiling"},{"DescriptorName":"Gene Expression Regulation"},{"DescriptorName":"Genetic Variation"},{"DescriptorName":"Humans"},{"DescriptorName":"Intercellular Signaling Peptides and Proteins","QualifierName":["genetics","metabolism"]},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Mutation"},{"DescriptorName":"Neurodegenerative Diseases","QualifierName":"genetics"},{"DescriptorName":"Oligonucleotide Array Sequence Analysis"},{"DescriptorName":"Progranulins"},{"DescriptorName":"Reverse Transcriptase Polymerase Chain Reaction"},{"DescriptorName":"Signal Transduction"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2008","Month":"1","Day":"29","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2008","Month":"6","Day":"24","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2008","Month":"1","Day":"29","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["18223198","ddn023","10.1093\/hmg\/ddn023","PMC2900863"]},"ReferenceList":{"Reference":[{"Citation":"Curr Opin Genet Dev. 2006 Dec;16(6):637-44","ArticleIdList":{"ArticleId":"17005391"}},{"Citation":"Nucleic Acids Res. 2006 Jan 1;34(Database issue):D354-7","ArticleIdList":{"ArticleId":"16381885"}},{"Citation":"Arch Neurol. 2007 Aug;64(8):1148-53","ArticleIdList":{"ArticleId":"17698705"}},{"Citation":"Cell. 1993 Apr 9;73(1):23-33","ArticleIdList":{"ArticleId":"8462100"}},{"Citation":"Acta Neuropathol. 2007 Jul;114(1):39-47","ArticleIdList":{"ArticleId":"17572900"}},{"Citation":"BMC Genomics. 2007;8:26","ArticleIdList":{"ArticleId":"17244347"}},{"Citation":"Arch Neurol. 2008 May;65(5):636-41","ArticleIdList":{"ArticleId":"18474740"}},{"Citation":"J Mol Biol. 2005 May 6;348(3):575-88","ArticleIdList":{"ArticleId":"15826655"}},{"Citation":"J Biol Chem. 2001 Sep 28;276(39):36337-43","ArticleIdList":{"ArticleId":"11470789"}},{"Citation":"Nature. 2006 Oct 19;443(7113):774-9","ArticleIdList":{"ArticleId":"17051203"}},{"Citation":"Ann Neurol. 2007 May;61(5):427-34","ArticleIdList":{"ArticleId":"17469116"}},{"Citation":"Cell. 2006 May 19;125(4):801-14","ArticleIdList":{"ArticleId":"16713569"}},{"Citation":"Brain. 2007 May;130(Pt 5):1360-74","ArticleIdList":{"ArticleId":"17439980"}},{"Citation":"Acta Neuropathol. 2004 Nov;108(5):379-85","ArticleIdList":{"ArticleId":"15351890"}},{"Citation":"J Neurol Neurosurg Psychiatry. 1994 Apr;57(4):416-8","ArticleIdList":{"ArticleId":"8163988"}},{"Citation":"EMBO J. 2001 Apr 2;20(7):1774-84","ArticleIdList":{"ArticleId":"11285240"}},{"Citation":"Brain. 2006 Nov;129(Pt 11):3091-102","ArticleIdList":{"ArticleId":"17003069"}},{"Citation":"Nature. 2006 Aug 24;442(7105):920-4","ArticleIdList":{"ArticleId":"16862115"}},{"Citation":"Ann Neurol. 2006 Jun;59(6):952-62","ArticleIdList":{"ArticleId":"16718704"}},{"Citation":"Methods. 2001 Dec;25(4):402-8","ArticleIdList":{"ArticleId":"11846609"}},{"Citation":"Mol Cell Neurosci. 2007 Jun;35(2):320-7","ArticleIdList":{"ArticleId":"17481916"}},{"Citation":"J Biol Chem. 2005 Nov 11;280(45):37572-84","ArticleIdList":{"ArticleId":"16157593"}},{"Citation":"Int Rev Neurobiol. 2004;60:25-58","ArticleIdList":{"ArticleId":"15474586"}},{"Citation":"Am J Pathol. 2006 Oct;169(4):1343-52","ArticleIdList":{"ArticleId":"17003490"}},{"Citation":"Nat Biotechnol. 2006 Sep;24(9):1151-61","ArticleIdList":{"ArticleId":"16964229"}},{"Citation":"Neuron. 1994 Oct;13(4):975-88","ArticleIdList":{"ArticleId":"7946341"}},{"Citation":"Nature. 2006 Oct 19;443(7113):787-95","ArticleIdList":{"ArticleId":"17051205"}},{"Citation":"Nucleic Acids Res. 2005;33(18):6000-10","ArticleIdList":{"ArticleId":"16254078"}},{"Citation":"Neurology. 2007 Sep 11;69(11):1113-21","ArticleIdList":{"ArticleId":"17522386"}},{"Citation":"Acta Neuropathol. 2007 Jul;114(1):5-22","ArticleIdList":{"ArticleId":"17579875"}},{"Citation":"Neurosci Lett. 2007 May 23;419(1):1-4","ArticleIdList":{"ArticleId":"17434264"}},{"Citation":"Brain. 2006 Nov;129(Pt 11):3081-90","ArticleIdList":{"ArticleId":"17071926"}},{"Citation":"J Neurosci. 2007 Sep 26;27(39):10530-4","ArticleIdList":{"ArticleId":"17898224"}},{"Citation":"Science. 2006 Oct 6;314(5796):130-3","ArticleIdList":{"ArticleId":"17023659"}},{"Citation":"J Neuropathol Exp Neurol. 2005 Aug;64(8):730-9","ArticleIdList":{"ArticleId":"16106222"}},{"Citation":"Genome Biol. 2004;5(10):R80","ArticleIdList":{"ArticleId":"15461798"}},{"Citation":"Ann Neurol. 2006 Sep;60(3):374-80","ArticleIdList":{"ArticleId":"16983677"}},{"Citation":"Bioinformatics. 2004 Feb 12;20(3):307-15","ArticleIdList":{"ArticleId":"14960456"}},{"Citation":"Nat Med. 2004 Jul;10 Suppl:S18-25","ArticleIdList":{"ArticleId":"15298006"}},{"Citation":"Acta Neuropathol. 2007 Jul;114(1):81-94","ArticleIdList":{"ArticleId":"17569064"}},{"Citation":"Stat Appl Genet Mol Biol. 2004;3:Article3","ArticleIdList":{"ArticleId":"16646809"}},{"Citation":"Hum Mol Genet. 2006 Oct 15;15(20):2988-3001","ArticleIdList":{"ArticleId":"16950801"}},{"Citation":"Genome Biol. 2003;4(5):P3","ArticleIdList":{"ArticleId":"12734009"}},{"Citation":"J Virol. 1995 Jun;69(6):3584-96","ArticleIdList":{"ArticleId":"7745706"}},{"Citation":"Hum Mol Genet. 2006 Mar 15;15(6):965-77","ArticleIdList":{"ArticleId":"16467349"}},{"Citation":"J Neuropathol Exp Neurol. 1984 Sep;43(5):461-70","ArticleIdList":{"ArticleId":"6540799"}},{"Citation":"Ann Neurol. 2005 Aug;58(2):242-57","ArticleIdList":{"ArticleId":"16049922"}},{"Citation":"Acta Neuropathol. 2007 May;113(5):535-42","ArticleIdList":{"ArticleId":"17333220"}},{"Citation":"Am J Pathol. 2007 Jul;171(1):227-40","ArticleIdList":{"ArticleId":"17591968"}},{"Citation":"Neurology. 1998 Dec;51(6):1546-54","ArticleIdList":{"ArticleId":"9855500"}},{"Citation":"BMC Mol Biol. 2006;7:3","ArticleIdList":{"ArticleId":"16448564"}},{"Citation":"Nature. 2006 Aug 24;442(7105):916-9","ArticleIdList":{"ArticleId":"16862116"}},{"Citation":"Biochem Biophys Res Commun. 2006 Dec 22;351(3):602-11","ArticleIdList":{"ArticleId":"17084815"}},{"Citation":"Neurobiol Aging. 2002 Sep-Oct;23(5):861-80","ArticleIdList":{"ArticleId":"12392791"}},{"Citation":"Nat Med. 2004 Jul;10 Suppl:S2-9","ArticleIdList":{"ArticleId":"15272266"}},{"Citation":"Neurology. 2002 Jun 11;58(11):1615-21","ArticleIdList":{"ArticleId":"12058088"}},{"Citation":"Arch Neurol. 2001 Nov;58(11):1803-9","ArticleIdList":{"ArticleId":"11708987"}},{"Citation":"Proc Natl Acad Sci U S A. 2004 Feb 17;101(7):2173-8","ArticleIdList":{"ArticleId":"14769913"}},{"Citation":"Bioinformatics. 2007 Aug 15;23(16):2129-38","ArticleIdList":{"ArticleId":"17553855"}},{"Citation":"Acta Neuropathol. 2007 Jul;114(1):63-70","ArticleIdList":{"ArticleId":"17492294"}},{"Citation":"Nat Genet. 2000 May;25(1):25-9","ArticleIdList":{"ArticleId":"10802651"}},{"Citation":"Genomics. 2004 Jan;83(1):130-9","ArticleIdList":{"ArticleId":"14667816"}},{"Citation":"Nucleic Acids Res. 2003 Feb 15;31(4):e15","ArticleIdList":{"ArticleId":"12582260"}},{"Citation":"Acta Neuropathol. 2007 Jul;114(1):49-54","ArticleIdList":{"ArticleId":"17458552"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"18053747","DateCompleted":{"Year":"2008","Month":"05","Day":"12"},"DateRevised":{"Year":"2018","Month":"11","Day":"13"},"Article":{"@attributes":{"PubModel":"Print-Electronic"},"Journal":{"ISSN":"1053-8119","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"39","Issue":"4","PubDate":{"Year":"2008","Month":"Feb","Day":"15"}},"Title":"NeuroImage","ISOAbbreviation":"Neuroimage"},"ArticleTitle":"Spatial patterns of brain atrophy in MCI patients, identified via high-dimensional pattern classification, predict subsequent cognitive decline.","Pagination":{"MedlinePgn":"1731-43"},"Abstract":{"AbstractText":"Spatial patterns of brain atrophy in mild cognitive impairment (MCI) and Alzheimer's disease (AD) were measured via methods of computational neuroanatomy. These patterns were spatially complex and involved many brain regions. In addition to the hippocampus and the medial temporal lobe gray matter, a number of other regions displayed significant atrophy, including orbitofrontal and medial-prefrontal grey matter, cingulate (mainly posterior), insula, uncus, and temporal lobe white matter. Approximately 2\/3 of the MCI group presented patterns of atrophy that overlapped with AD, whereas the remaining 1\/3 overlapped with cognitively normal individuals, thereby indicating that some, but not all, MCI patients have significant and extensive brain atrophy in this cohort of MCI patients. Importantly, the group with AD-like patterns presented much higher rate of MMSE decline in follow-up visits; conversely, pattern classification provided relatively high classification accuracy (87%) of the individuals that presented relatively higher MMSE decline within a year from baseline. High-dimensional pattern classification, a nonlinear multivariate analysis, provided measures of structural abnormality that can potentially be useful for individual patient classification, as well as for predicting progression and examining multivariate relationships in group analyses."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Fan","ForeName":"Yong","Initials":"Y","AffiliationInfo":{"Affiliation":"Section of Biomedical Image Analysis, Department of Radiology, University of Pennsylvania, School of Medicine, Philadelphia, PA 19104, USA."}},{"@attributes":{"ValidYN":"Y"},"LastName":"Batmanghelich","ForeName":"Nematollah","Initials":"N"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris M","Initials":"CM"},{"@attributes":{"ValidYN":"Y"},"LastName":"Davatzikos","ForeName":"Christos","Initials":"C"},{"@attributes":{"ValidYN":"Y"},"CollectiveName":"Alzheimer's Disease Neuroimaging Initiative"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":[{"GrantID":"R01 AG 14971","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"U01 AG 024904","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"U01 AG024904","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"U19 AG010483","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R01 AG014971","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R01 AG014971-09","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"},{"GrantID":"R01 AG014971-08S1","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"}]},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, N.I.H., Extramural","Research Support, Non-U.S. Gov't"]},"ArticleDate":{"@attributes":{"DateType":"Electronic"},"Year":"2007","Month":"11","Day":"01"}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Neuroimage","NlmUniqueID":"9215515","ISSNLinking":"1053-8119"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Algorithms"},{"DescriptorName":"Alzheimer Disease","QualifierName":["pathology","psychology"]},{"DescriptorName":"Atrophy"},{"DescriptorName":"Brain","QualifierName":"pathology"},{"DescriptorName":"Cognition Disorders","QualifierName":["pathology","psychology"]},{"DescriptorName":"Female"},{"DescriptorName":"Humans"},{"DescriptorName":"Image Processing, Computer-Assisted","QualifierName":"methods"},{"DescriptorName":"Infarction, Middle Cerebral Artery","QualifierName":["pathology","psychology"]},{"DescriptorName":"Magnetic Resonance Imaging"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Multivariate Analysis"},{"DescriptorName":"Neuropsychological Tests"},{"DescriptorName":"Nonlinear Dynamics"},{"DescriptorName":"Pattern Recognition, Automated","QualifierName":"methods"},{"DescriptorName":"Prognosis"},{"DescriptorName":"ROC Curve"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"received"},"Year":"2007","Month":"07","Day":"06"},{"@attributes":{"PubStatus":"revised"},"Year":"2007","Month":"10","Day":"04"},{"@attributes":{"PubStatus":"accepted"},"Year":"2007","Month":"10","Day":"24"},{"@attributes":{"PubStatus":"pubmed"},"Year":"2007","Month":"12","Day":"7","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2008","Month":"5","Day":"13","Hour":"9","Minute":"0"},{"@attributes":{"PubStatus":"entrez"},"Year":"2007","Month":"12","Day":"7","Hour":"9","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["18053747","S1053-8119(07)00965-2","10.1016\/j.neuroimage.2007.10.031","PMC2861339","NIHMS165514"]},"ReferenceList":{"Reference":[{"Citation":"J Neurosci. 2003 Apr 15;23(8):3295-301","ArticleIdList":{"ArticleId":"12716936"}},{"Citation":"Neurology. 2004 Apr 13;62(7):1148-55","ArticleIdList":{"ArticleId":"15079015"}},{"Citation":"Neurology. 2006 Sep 12;67(5):834-42","ArticleIdList":{"ArticleId":"16966547"}},{"Citation":"Neuroimage. 2003 Feb;18(2):525-41","ArticleIdList":{"ArticleId":"12595205"}},{"Citation":"Acta Neuropathol. 1999 Apr;97(4):359-68","ArticleIdList":{"ArticleId":"10208275"}},{"Citation":"Neurology. 2003 Apr 22;60(8):1374-7","ArticleIdList":{"ArticleId":"12707450"}},{"Citation":"Med Image Comput Comput Assist Interv. 2005;8(Pt 1):1-8","ArticleIdList":{"ArticleId":"16685822"}},{"Citation":"Neurobiol Aging. 1997 Mar-Apr;18(2):131-8","ArticleIdList":{"ArticleId":"9258889"}},{"Citation":"Neurobiol Aging. 2005 Aug-Sep;26(8):1193-8","ArticleIdList":{"ArticleId":"15917103"}},{"Citation":"NMR Biomed. 2002 Nov-Dec;15(7-8):553-60","ArticleIdList":{"ArticleId":"12489101"}},{"Citation":"Neuroreport. 1998 Feb 16;9(3):533-7","ArticleIdList":{"ArticleId":"9512402"}},{"Citation":"Alcohol Clin Exp Res. 2006 Nov;30(11):1866-70","ArticleIdList":{"ArticleId":"17067350"}},{"Citation":"Neurology. 2005 May 10;64(9):1520-4","ArticleIdList":{"ArticleId":"15883311"}},{"Citation":"Biol Psychiatry. 2008 Jan 1;63(1):118-24","ArticleIdList":{"ArticleId":"17555720"}},{"Citation":"Neurology. 1999 Apr 22;52(7):1397-403","ArticleIdList":{"ArticleId":"10227624"}},{"Citation":"Neurobiol Aging. 2000 Jan-Feb;21(1):19-26","ArticleIdList":{"ArticleId":"10794844"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2002 Jun;72(6):742-6","ArticleIdList":{"ArticleId":"12023417"}},{"Citation":"Arch Gen Psychiatry. 2005 Nov;62(11):1218-27","ArticleIdList":{"ArticleId":"16275809"}},{"Citation":"Ann N Y Acad Sci. 2007 Feb;1097:259-64","ArticleIdList":{"ArticleId":"17413027"}},{"Citation":"Neurology. 1997 May;48(5):1297-304","ArticleIdList":{"ArticleId":"9153461"}},{"Citation":"Neurobiol Aging. 2000 Mar-Apr;21(2):207-14","ArticleIdList":{"ArticleId":"10867205"}},{"Citation":"Neurology. 2006 May 23;66(10):1476-84","ArticleIdList":{"ArticleId":"16717205"}},{"Citation":"Neuroimage. 2004 Oct;23(2):708-16","ArticleIdList":{"ArticleId":"15488420"}},{"Citation":"Neurology. 2006 Aug 8;67(3):453-60","ArticleIdList":{"ArticleId":"16894107"}},{"Citation":"Neuroimage. 2001 Dec;14(6):1361-9","ArticleIdList":{"ArticleId":"11707092"}},{"Citation":"Neurology. 2002 Sep 24;59(6):874-9","ArticleIdList":{"ArticleId":"12297570"}},{"Citation":"Neuroimage. 2005 Nov 15;28(3):663-8","ArticleIdList":{"ArticleId":"16169252"}},{"Citation":"J Comput Assist Tomogr. 1998 Sep-Oct;22(5):827-37","ArticleIdList":{"ArticleId":"9754125"}},{"Citation":"Neuroimage. 2002 Sep;17(1):29-46","ArticleIdList":{"ArticleId":"12482066"}},{"Citation":"Neurobiol Aging. 2001 Sep-Oct;22(5):747-54","ArticleIdList":{"ArticleId":"11705634"}},{"Citation":"Psychiatry Res. 2006 Apr 30;146(3):243-9","ArticleIdList":{"ArticleId":"16520023"}},{"Citation":"Neurology. 2000 May 9;54(9):1760-7","ArticleIdList":{"ArticleId":"10802781"}},{"Citation":"Neurobiol Aging. 2006 May;27(5):663-72","ArticleIdList":{"ArticleId":"16005548"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2005 Jan;76(1):11-4","ArticleIdList":{"ArticleId":"15607988"}},{"Citation":"Dement Geriatr Cogn Disord. 2004;18(1):101-8","ArticleIdList":{"ArticleId":"15087585"}},{"Citation":"Neurology. 2007 May 8;68(19):1603-6","ArticleIdList":{"ArticleId":"17485647"}},{"Citation":"Psychiatry Res. 2006 Apr 30;146(3):283-7","ArticleIdList":{"ArticleId":"16530394"}},{"Citation":"Neurobiol Aging. 2001 Jul-Aug;22(4):529-39","ArticleIdList":{"ArticleId":"11445252"}},{"Citation":"Neuroimage. 2004 Jan;21(1):46-57","ArticleIdList":{"ArticleId":"14741641"}},{"Citation":"J Neural Transm Suppl. 1998;54:97-106","ArticleIdList":{"ArticleId":"9850918"}},{"Citation":"Brain Res. 2000 Jan 17;853(1):1-4","ArticleIdList":{"ArticleId":"10627301"}},{"Citation":"IEEE Trans Med Imaging. 1999 Sep;18(9):737-52","ArticleIdList":{"ArticleId":"10571379"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2002 Apr;72(4):491-7","ArticleIdList":{"ArticleId":"11909909"}},{"Citation":"J Geriatr Psychiatry Neurol. 2005 Mar;18(1):12-9","ArticleIdList":{"ArticleId":"15681623"}},{"Citation":"Acta Neurochir (Wien). 2001;143(3):287-95","ArticleIdList":{"ArticleId":"11460917"}},{"Citation":"Neuroimage. 2002 Feb;15(2):422-34","ArticleIdList":{"ArticleId":"11798276"}},{"Citation":"Artif Intell Med. 2006 Mar;36(3):245-55","ArticleIdList":{"ArticleId":"16427257"}},{"Citation":"Neuroimage. 2005 Jun;26(2):317-29","ArticleIdList":{"ArticleId":"15907293"}},{"Citation":"JAMA. 1997 Mar 12;277(10):813-7","ArticleIdList":{"ArticleId":"9052711"}},{"Citation":"J Neurol Neurosurg Psychiatry. 2001 Oct;71(4):441-7","ArticleIdList":{"ArticleId":"11561025"}},{"Citation":"Neuroreport. 2002 Oct 28;13(15):1939-43","ArticleIdList":{"ArticleId":"12395096"}},{"Citation":"J Mol Neurosci. 2002 Aug-Oct;19(1-2):23-7","ArticleIdList":{"ArticleId":"12212787"}},{"Citation":"Neurology. 2003 Apr 8;60(7):1082-8","ArticleIdList":{"ArticleId":"12682310"}},{"Citation":"J Stud Alcohol. 2006 Nov;67(6):861-7","ArticleIdList":{"ArticleId":"17061003"}},{"Citation":"Neurobiol Aging. 2006 Mar;27(3):394-401","ArticleIdList":{"ArticleId":"16125823"}},{"Citation":"Lancet Neurol. 2003 Feb;2(2):79-88","ArticleIdList":{"ArticleId":"12849264"}},{"Citation":"Neurology. 2000 Aug 22;55(4):484-89","ArticleIdList":{"ArticleId":"10953178"}},{"Citation":"J Alzheimers Dis. 2005 Jun;7(3):187-99; discussion 255-62","ArticleIdList":{"ArticleId":"16006662"}},{"Citation":"Neurology. 2006 Jun 27;66(12):1845-9","ArticleIdList":{"ArticleId":"16801648"}},{"Citation":"Neuroimage. 2005 Dec;28(4):980-95","ArticleIdList":{"ArticleId":"16275139"}},{"Citation":"Neuroimage. 2003 Jan;18(1):28-41","ArticleIdList":{"ArticleId":"12507441"}},{"Citation":"IEEE Trans Med Imaging. 2007 Jan;26(1):93-105","ArticleIdList":{"ArticleId":"17243588"}},{"Citation":"Cereb Cortex. 2001 Jan;11(1):1-16","ArticleIdList":{"ArticleId":"11113031"}},{"Citation":"Brain. 2007 Jul;130(Pt 7):1777-86","ArticleIdList":{"ArticleId":"17533169"}},{"Citation":"Neuroimage. 2005 Apr 15;25(3):783-92","ArticleIdList":{"ArticleId":"15808979"}},{"Citation":"IEEE Trans Med Imaging. 2002 Nov;21(11):1421-39","ArticleIdList":{"ArticleId":"12575879"}},{"Citation":"Neurobiol Aging. 2008 Apr;29(4):514-23","ArticleIdList":{"ArticleId":"17174012"}},{"Citation":"Ann Neurol. 2000 Apr;47(4):430-9","ArticleIdList":{"ArticleId":"10762153"}},{"Citation":"Cereb Cortex. 2000 May;10(5):464-72","ArticleIdList":{"ArticleId":"10847596"}},{"Citation":"AJNR Am J Neuroradiol. 2007 Aug;28(7):1339-45","ArticleIdList":{"ArticleId":"17698538"}},{"Citation":"Radiology. 2006 Oct;241(1):197-205","ArticleIdList":{"ArticleId":"16990677"}},{"Citation":"Arch Neurol. 2004 Oct;61(10):1531-4","ArticleIdList":{"ArticleId":"15477506"}}]}}},{"MedlineCitation":{"@attributes":{"Status":"MEDLINE","Owner":"NLM"},"PMID":"12040307","DateCompleted":{"Year":"2002","Month":"07","Day":"08"},"DateRevised":{"Year":"2019","Month":"12","Day":"10"},"Article":{"@attributes":{"PubModel":"Print"},"Journal":{"ISSN":"0893-0341","JournalIssue":{"@attributes":{"CitedMedium":"Print"},"Volume":"16","Issue":"2","PubDate":{"MedlineDate":"2002 Apr-Jun"}},"Title":"Alzheimer disease and associated disorders","ISOAbbreviation":"Alzheimer Dis Assoc Disord"},"ArticleTitle":"How should clinicians discuss hospice for patients with dementia? Anticipating caregivers' preconceptions and meeting their information needs.","Pagination":{"MedlinePgn":"116-22"},"Abstract":{"AbstractText":"This study was designed to determine whether Alzheimer disease (AD) caregivers view the benefits of hospice as more relevant to themselves or to patients, to identify the features of hospice care that are most important to caregivers, and to determine how often these features are described in hospice promotional materials. Telephone interviews were conducted with AD caregivers from a Memory Disorders Clinic of an urban academic medical center (N = 45). A nationwide mail survey of randomly selected hospices was also conducted (N = 66). Caregivers were twice as likely to say that hospice would benefit them than they were to say it would benefit the patient (26 vs. 13; p = 0.002). The features of hospice that were most important to caregivers were continued follow-up evaluation by the patient's primary care provider and hospice's emphasis on helping patients to avoid hospital admission. The least important was the availability of a chaplain. There was moderate agreement between the importance of various hospice features to caregivers, and the representation of that feature in hospice promotional materials. AD caregivers have generally positive opinions about hospice's benefits for themselves. In discussing hospice with AD caregivers, clinicians may want to emphasize selected features of hospice that are particularly important to caregivers."},"AuthorList":{"@attributes":{"CompleteYN":"Y"},"Author":[{"@attributes":{"ValidYN":"Y"},"LastName":"Casarett","ForeName":"David","Initials":"D","AffiliationInfo":{"Affiliation":"Philadelphia Veterans Administration Medical Center, Philadelphia, Pennsylvania, USA. Casarett@mail.med.upenn.edu"}},{"@attributes":{"ValidYN":"Y"},"LastName":"Takesaka","ForeName":"Jennifer","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Karlawish","ForeName":"Jason","Initials":"J"},{"@attributes":{"ValidYN":"Y"},"LastName":"Hirschman","ForeName":"Karen B","Initials":"KB"},{"@attributes":{"ValidYN":"Y"},"LastName":"Clark","ForeName":"Chris M","Initials":"CM"}]},"Language":"eng","GrantList":{"@attributes":{"CompleteYN":"Y"},"Grant":{"GrantID":"K01-AG00931","Acronym":"AG","Agency":"NIA NIH HHS","Country":"United States"}},"PublicationTypeList":{"PublicationType":["Journal Article","Research Support, Non-U.S. Gov't","Research Support, U.S. Gov't, Non-P.H.S.","Research Support, U.S. Gov't, P.H.S."]}},"MedlineJournalInfo":{"Country":"United States","MedlineTA":"Alzheimer Dis Assoc Disord","NlmUniqueID":"8704771","ISSNLinking":"0893-0341"},"CitationSubset":"IM","MeshHeadingList":{"MeshHeading":[{"DescriptorName":"Adult"},{"DescriptorName":"Advertising"},{"DescriptorName":"Aged"},{"DescriptorName":"Aged, 80 and over"},{"DescriptorName":"Attitude to Health"},{"DescriptorName":"Caregivers","QualifierName":"psychology"},{"DescriptorName":"Dementia","QualifierName":"therapy"},{"DescriptorName":"Female"},{"DescriptorName":"Health Surveys"},{"DescriptorName":"Hospice Care"},{"DescriptorName":"Humans"},{"DescriptorName":"Informed Consent"},{"DescriptorName":"Male"},{"DescriptorName":"Middle Aged"},{"DescriptorName":"Physician-Patient Relations"}]}},"PubmedData":{"History":{"PubMedPubDate":[{"@attributes":{"PubStatus":"pubmed"},"Year":"2002","Month":"6","Day":"1","Hour":"10","Minute":"0"},{"@attributes":{"PubStatus":"medline"},"Year":"2002","Month":"7","Day":"9","Hour":"10","Minute":"1"},{"@attributes":{"PubStatus":"entrez"},"Year":"2002","Month":"6","Day":"1","Hour":"10","Minute":"0"}]},"PublicationStatus":"ppublish","ArticleIdList":{"ArticleId":["12040307","10.1097\/00002093-200204000-00009"]}}}]}